x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
New York
|
|
81-2983623
|
(State of incorporation)
|
|
(IRS Employer Identification No.)
|
100 Campus Drive
Florham Park, New Jersey 07932
|
|
(973) 261-7100
|
(Address of principal executive offices)
|
|
(Registrants telephone number, including area code)
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
|
New York Stock Exchange
|
Class
|
|
Outstanding at February 28, 2017
|
Common Stock, $0.01 par value
|
|
203,630,042
|
Document
|
|
Part of Form 10-K in which Incorporated
|
Conduent Incorporated Notice of 2017 Annual Meeting of Shareholders and Proxy Statement (to be filed no later than 120 days after the close of the fiscal year covered by this report on Form 10-K)
|
|
III
|
|
Page
|
|
Part I
|
|
|
Item 1.
|
Business
|
|
Item 1A.
|
Risk Factors
|
|
Item 1B.
|
Unresolved Staff Comments
|
|
Item 2.
|
Properties
|
|
Item 3.
|
Legal Proceedings
|
|
Item 4.
|
Mine Safety Disclosures
|
|
Part II
|
|
|
Item 5.
|
Market for the Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
Item 6.
|
Selected Financial Data
|
|
Item 7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
Item 9A.
|
Controls and Procedures
|
|
Item 9B.
|
Other Information
|
|
Part III
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
Item 11.
|
Executive Compensation
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
Item 13.
|
Certain Relationships, Related Transactions and Director Independence
|
|
Item 14.
|
Principal Auditor Fees and Services
|
|
Part IV
|
|
|
Item 15.
|
Exhibits and Financial Statement Schedules
|
|
Item 16.
|
Form 10-K Summary
|
|
Signatures
|
.
|
|
Schedule II
|
Valuation and Qualifying Accounts
|
|
Index of Exhibits
|
•
|
Increased Use of Automation.
We have developed and deployed a set of advanced software-based automation tools as part of our service delivery operations. These tools reduce the amount of repetitive, manual labor required to deliver many of our services and improve service quality through lower error rates and faster processing times.
|
•
|
Our
Commercial Industries
segment provides business process services and customized solutions to clients in a variety of industries (other than healthcare).
|
•
|
Our
Healthcare
segment provides innovative industry-centric business process services to clients across the healthcare industry, including providers, payers, employers, pharmaceutical and life science companies and government agencies.
|
•
|
Our
Public Sector
segment provides government-centric business process services and subject matter experts to U.S. federal, state and local and foreign governments.
|
•
|
Our Government Health Enterprise (“HE”) Medicaid Platform for all current state clients and Student Loan businesses, as well as non-allocated expenses and inter-segment eliminations, are included in Other.
|
•
|
Transaction Processing
: We provide high volume print and mail services, enrollment processing and personalized and targeted marketing and communications, to large corporations and we believe we are a leading provider in this market.
|
•
|
Prepaid Cards
: We are the leading provider of prepaid payment card services in support of the U.S. government prepaid card services market.
|
•
|
Large multinational service providers such as CGI Group, Computer Sciences, Accenture, Aon Hewitt, Cognizant, Hewlett-Packard Enterprise, IBM, Teletech, and Teleperformance;
|
•
|
Payroll processing and human capital management providers such as ADP and Paychex;
|
•
|
Healthcare-focused IT and service solutions providers such as Cerner, Quintiles, and Maximus;
|
•
|
U.S. Federal focused government services such as CACI International; and
|
•
|
Smaller niche business processing service providers and in-house departments that perform functions that could be outsourced to us.
|
•
|
incur or guarantee additional indebtedness or sell disqualified or preferred stock;
|
•
|
pay dividends on, make distributions in respect of, repurchase or redeem, capital stock;
|
•
|
make investments or acquisitions;
|
•
|
sell, transfer or otherwise dispose of certain assets, including accounts receivable;
|
•
|
create liens;
|
•
|
enter into sale/leaseback transactions;
|
•
|
enter into agreements restricting the ability to pay dividends or make other intercompany transfers;
|
•
|
consolidate, merge, sell or otherwise dispose of all or substantially all of our or our subsidiaries’ assets;
|
•
|
enter into transactions with affiliates;
|
•
|
prepay, repurchase or redeem certain kinds of indebtedness;
|
•
|
issue or sell stock of our subsidiaries; and/or
|
•
|
significantly change the nature of our business.
|
•
|
limited in how we conduct our business and pursue our strategy; unable to raise additional debt financing to operate during general economic or business downturns; or
|
•
|
unable to compete effectively or to take advantage of new business opportunities.
|
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012 (unaudited)
|
||||||||||
Per-Share Data
|
|
|
|
|
|
|
|
|
|
|
||||||||||
(Loss) income from continuing operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
(4.85
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
0.17
|
|
|
$
|
0.67
|
|
|
$
|
0.68
|
|
Diluted
|
|
(4.85
|
)
|
|
(1.65
|
)
|
|
0.17
|
|
|
0.67
|
|
|
0.68
|
|
|||||
Net (loss) income attributable to Conduent
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
(4.85
|
)
|
|
(2.04
|
)
|
|
(0.40
|
)
|
|
0.90
|
|
|
0.84
|
|
|||||
Diluted
|
|
(4.85
|
)
|
|
(2.04
|
)
|
|
(0.40
|
)
|
|
0.90
|
|
|
0.84
|
|
|||||
Common stock dividends declared
(1)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenues
|
|
$
|
6,408
|
|
|
$
|
6,662
|
|
|
$
|
6,938
|
|
|
$
|
6,879
|
|
|
$
|
6,873
|
|
(Loss) income from continuing operations
|
|
(983
|
)
|
|
(336
|
)
|
|
34
|
|
|
135
|
|
|
137
|
|
|||||
Net (loss) income
|
|
(983
|
)
|
|
(414
|
)
|
|
(81
|
)
|
|
182
|
|
|
170
|
|
|||||
Financial Position
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Working capital
|
|
$
|
515
|
|
|
$
|
(867
|
)
|
|
$
|
(887
|
)
|
|
$
|
(1,450
|
)
|
|
$
|
(1,975
|
)
|
Total Assets
|
|
7,709
|
|
|
9,058
|
|
|
10,954
|
|
|
11,205
|
|
|
11,217
|
|
|||||
Consolidated Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Short-term debt and current portion of long-term debt
|
|
$
|
28
|
|
|
$
|
24
|
|
|
$
|
268
|
|
|
$
|
42
|
|
|
$
|
37
|
|
Long-term debt
|
|
1,913
|
|
|
37
|
|
|
43
|
|
|
310
|
|
|
292
|
|
|||||
Total Debt
(2)
|
|
1,941
|
|
|
61
|
|
|
311
|
|
|
352
|
|
|
329
|
|
|||||
Series A preferred stock
|
|
142
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|||||
Conduent shareholders' equity/former parent investment
|
|
3,288
|
|
|
5,162
|
|
|
5,411
|
|
|
5,579
|
|
|
5,408
|
|
|||||
Total Consolidated Capitalization
|
|
$
|
5,371
|
|
|
$
|
5,223
|
|
|
$
|
5,722
|
|
|
$
|
5,931
|
|
|
$
|
5,737
|
|
Selected Data and Ratios
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
We did not declare or pay dividends for the periods presented.
|
(2)
|
Includes capital lease obligations.
|
(3)
|
Selected data and ratios are not provided as the common stock of Conduent Incorporated did not begin "regular way" trading on the NYSE until January 3, 2017.
|
•
|
Our
Commercial Industries
segment is comprised of business process services and customized solutions offered to clients in a variety of industries (other than healthcare).
|
•
|
Our
Healthcare
segment is comprised of industry-centric business process services offered to clients across the healthcare industry, including providers, payers, employers, pharmaceutical and life science companies and government agencies.
|
•
|
Our
Public Sector
segment is comprised of government-centric business process services offered to U.S. federal, state and local governments, as well as foreign.
|
•
|
significant underperformance relative to historical or projected future operating results;
|
•
|
significant changes in the manner of our use of the acquired assets or the strategy for our overall business; and
|
•
|
significant negative industry or economic trends.
|
|
Revenues
|
|
% Change
|
|
CC % Change
|
||||||||||||||||||
(in millions)
|
2016
|
|
2015
|
|
2014
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||||
Total Revenues
|
$
|
6,408
|
|
|
$
|
6,662
|
|
|
$
|
6,938
|
|
|
(4
|
)%
|
|
(4
|
)%
|
|
(3
|
)%
|
|
(2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted Total Revenues
(1)
|
$
|
6,491
|
|
|
$
|
6,778
|
|
|
$
|
6,938
|
|
|
(4
|
)%
|
|
(2
|
)%
|
|
(3
|
)%
|
|
—
|
%
|
CC -
|
Refer to the "Non-GAAP Financial Measures" section for description of Constant Currency
|
(1)
|
Refer to the "Non-GAAP Financial Measures" section for an explanation of this non-GAAP financial measure.
|
(1)
|
Refer to the "Non-GAAP Financial Measures" section for an explanation of the non-GAAP financial measure.
|
|
Year Ended December 31,
|
|
Change B/(W)
|
|
Adjusted
(1)
|
|
Adjusted
(1)
B/(W)
|
|||||||||||||||||||
|
2016
|
|
2015
|
|
2014
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|||||||||
Total Gross Margin
|
14.2
|
%
|
|
10.3
|
%
|
|
16.4
|
%
|
|
3.9 pts
|
|
|
(6.1) pts
|
|
|
16.5
|
%
|
|
15.8
|
%
|
|
0.7 pts
|
|
|
(0.6) pts
|
|
R&D as a % of Revenue
|
0.5
|
%
|
|
0.8
|
%
|
|
0.7
|
%
|
|
0.3 pts
|
|
|
(0.1) pts
|
|
|
0.5
|
%
|
|
0.8
|
%
|
|
0.3 pts
|
|
|
(0.1) pts
|
|
SAG as a % of Revenue
|
10.7
|
%
|
|
10.5
|
%
|
|
9.5
|
%
|
|
(0.2) pts
|
|
|
(1.0) pts
|
|
|
10.6
|
%
|
|
10.3
|
%
|
|
(0.3) pts
|
|
|
(0.8) pts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Pre-tax Income Margin
|
(19.1
|
)%
|
|
(8.6
|
)%
|
|
0.1
|
%
|
|
(10.5) pts
|
|
|
(8.7) pts
|
|
|
4.8
|
%
|
|
3.7
|
%
|
|
1.1 pts
|
|
|
3.6 pts
|
|
Operating Margin
(2)
|
3.0
|
%
|
|
(1.0
|
)%
|
|
6.2
|
%
|
|
4.0 pts
|
|
|
(7.2) pts
|
|
|
5.5
|
%
|
|
4.8
|
%
|
|
0.7 pts
|
|
|
(1.6) pts
|
|
(1)
|
Refer to Key Financial Ratios reconciliation table in the "Non-GAAP Financial Measures" section.
|
(2)
|
Refer to the Operating Income/Margin reconciliation table in the "Non-GAAP Financial Measures" section.
|
(1)
|
Refer to the Operating Income/Margin reconciliation table and the "Non-GAAP Financial Measures" section.
|
(1)
|
Refer to the Key Financial Ratios reconciliation table in the "Non-GAAP Financial Measures" section.
|
(1)
|
Refer to the Key Financial Ratios reconciliation table in the "Non-GAAP Financial Measures" section.
|
•
|
$24
million decrease in selling expenses;
|
•
|
$11 million increase in general and administrative expenses; and
|
•
|
bad debt expense of $4 million was flat as compared to the prior year and less than one percent of receivables.
|
•
|
$26 million increase in general and administrative expenses; and
|
•
|
$14 million increase in selling expenses.
|
(1)
|
Refer to the Key Financial Ratios reconciliation table in the "Non-GAAP Financial Measures" section.
|
•
|
$67 million of severance costs related to headcount reductions of approximately 3,600 employees globally. The actions impacted several functional areas and focused on gross margin improvements;
|
•
|
$7 million for lease termination costs, primarily reflecting continued optimization of our worldwide operating locations; and
|
•
|
$12 million of asset impairment charges.
|
•
|
$20 million of severance costs related to headcount reductions of approximately 1,000 employees globally. These actions impacted several functional areas and focused on gross margin improvements;
|
•
|
$1 million for lease termination costs, primarily reflecting continued optimization of our worldwide operating locations; and
|
•
|
$146 million of asset impairment charges associated with software asset impairments resulting from the change in strategy in our Government Healthcare business in 2015.
|
|
Year Ended December 31,
|
||||||||||
(in millions)
|
2016
|
|
2015
|
|
2014
|
||||||
Third-party interest expense
|
$
|
14
|
|
|
$
|
8
|
|
|
$
|
11
|
|
Gains on sales of businesses and assets
(1)
|
2
|
|
|
(1
|
)
|
|
(1
|
)
|
|||
Currency (gains) losses, net
|
(2
|
)
|
|
4
|
|
|
(1
|
)
|
|||
Litigation matters
|
40
|
|
|
18
|
|
|
38
|
|
|||
Deferred compensation investment (gains) losses
|
(8
|
)
|
|
1
|
|
|
(7
|
)
|
|||
Contingent consideration adjustment
|
(12
|
)
|
|
—
|
|
|
—
|
|
|||
All other expenses, net
|
—
|
|
|
8
|
|
|
5
|
|
|||
Total Other Expenses, Net
|
$
|
34
|
|
|
$
|
38
|
|
|
$
|
45
|
|
(1)
|
Excludes the loss on sale of the ITO business reported in Discontinued Operations. Refer to Note 4 - Divestitures in the Consolidated Financial Statements for additional information.
|
(1)
|
See the "Non-GAAP Financial Measures" section for an explanation of the adjusted effective tax rate non-GAAP financial measure.
|
(1)
|
See the "Non-GAAP Financial Measures" section for a reconciliation of reported net income from continuing operations to adjusted net income.
|
(in millions)
|
|
Total Revenue
|
|
% of Total Revenue
|
|
Segment Profit (Loss)
|
|
Segment Margin
|
||||||
2016
|
|
|
|
|
|
|
|
|
||||||
Commercial Industries
|
|
$
|
2,690
|
|
|
42
|
%
|
|
$
|
59
|
|
|
2.2
|
%
|
Healthcare
|
|
1,686
|
|
|
26
|
%
|
|
159
|
|
|
9.4
|
%
|
||
Public Sector
|
|
1,731
|
|
|
27
|
%
|
|
223
|
|
|
12.9
|
%
|
||
Other
|
|
301
|
|
|
5
|
%
|
|
(245
|
)
|
|
(81.4
|
)%
|
||
Total
|
|
$
|
6,408
|
|
|
100
|
%
|
|
$
|
196
|
|
|
3.1
|
%
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted:
(1)
|
|
|
|
|
|
|
|
|
||||||
Other
|
|
$
|
384
|
|
|
6
|
%
|
|
$
|
(84
|
)
|
|
(21.9
|
)%
|
Total
|
|
$
|
6,491
|
|
|
100
|
%
|
|
$
|
357
|
|
|
5.5
|
%
|
|
|
|
|
|
|
|
|
|
||||||
2015
|
|
|
|
|
|
|
|
|
||||||
Commercial Industries
|
|
$
|
2,896
|
|
|
44
|
%
|
|
$
|
69
|
|
|
2.4
|
%
|
Healthcare
|
|
1,750
|
|
|
26
|
%
|
|
157
|
|
|
9.0
|
%
|
||
Public Sector
|
|
1,727
|
|
|
26
|
%
|
|
200
|
|
|
11.6
|
%
|
||
Other
|
|
289
|
|
|
4
|
%
|
|
(489
|
)
|
|
*
|
|
||
Total
|
|
$
|
6,662
|
|
|
100
|
%
|
|
$
|
(63
|
)
|
|
(0.9
|
)%
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted:
(1)
|
|
|
|
|
|
|
|
|
||||||
Other
|
|
$
|
405
|
|
|
6
|
%
|
|
$
|
(100
|
)
|
|
(24.7
|
)%
|
Total
|
|
$
|
6,778
|
|
|
100
|
%
|
|
$
|
326
|
|
|
4.8
|
%
|
|
|
|
|
|
|
|
|
|
||||||
2014
|
|
|
|
|
|
|
|
|
||||||
Commercial Industries
|
|
$
|
2,953
|
|
|
43
|
%
|
|
$
|
152
|
|
|
5.1
|
%
|
Healthcare
|
|
1,743
|
|
|
25
|
%
|
|
138
|
|
|
7.9
|
%
|
||
Public Sector
|
|
1,767
|
|
|
25
|
%
|
|
206
|
|
|
11.7
|
%
|
||
Other
|
|
475
|
|
|
7
|
%
|
|
(49
|
)
|
|
(10.3
|
)%
|
||
Total
|
|
$
|
6,938
|
|
|
100
|
%
|
|
$
|
447
|
|
|
6.4
|
%
|
*
|
Percentage not meaningful
|
(1)
|
Refer to the reconciliations table in the "Non-GAAP Financial Measures" section.
|
(1)
|
Refer to the reconciliations table in the "Non-GAAP Financial Measures" section.
|
|
Year Ended December 31,
|
|
Change
|
||||||||||||||||
(in millions)
|
2016
|
|
2015
|
|
2014
|
|
2016
|
|
2015
|
||||||||||
Net cash provided by operating activities
|
$
|
108
|
|
|
$
|
493
|
|
|
$
|
665
|
|
|
$
|
(385
|
)
|
|
$
|
(172
|
)
|
Net cash provided by (used in) investing activities
|
16
|
|
|
522
|
|
|
(488
|
)
|
|
(506
|
)
|
|
1,010
|
|
|||||
Net cash provided by (used in) financing activities
|
132
|
|
|
(1,023
|
)
|
|
(149
|
)
|
|
1,155
|
|
|
(874
|
)
|
|||||
Effect of exchange rate changes on cash and cash equivalents
|
(6
|
)
|
|
(11
|
)
|
|
(8
|
)
|
|
5
|
|
|
(3
|
)
|
|||||
Increase (decrease) in cash and cash equivalents
|
250
|
|
|
(19
|
)
|
|
20
|
|
|
269
|
|
|
(39
|
)
|
|||||
Cash and cash equivalents at beginning of year
|
140
|
|
|
159
|
|
|
139
|
|
|
(19
|
)
|
|
20
|
|
|||||
Cash and Cash Equivalents at End of Year
|
$
|
390
|
|
|
$
|
140
|
|
|
$
|
159
|
|
|
$
|
250
|
|
|
$
|
(19
|
)
|
•
|
$12 million decrease in pre-tax income before depreciation and amortization, loss on sales of business, HE prior year charge, goodwill impairment charge, NY MMIS charge, separation-related costs and restructuring and related charges
.
|
•
|
$233 million decrease due to reduced factoring and timing of collections of accounts receivable in 2016
.
|
•
|
$136 million decrease reflecting settlement payments associated with our third quarter 2015 determination that we would not fully complete the HE implementations in California and Montana.
|
•
|
$82 million decrease in accounts payable and accrued compensation primarily due to the timing of payments.
|
•
|
$44 million decrease for payments for separation-related costs.
|
•
|
$39 million decrease due to the prior year source of cash in the discontinued ITO business.
|
•
|
$27 million decrease in restructuring payments as a result of increased restructuring initiatives in 2016
.
|
•
|
$317 million increase due to lower net income tax payments made in 2016 as a result of receiving refunds of prior year overpayments due to a change in tax treatment of unbilled revenue..
|
•
|
$21 million increase primarily from lower spending for product software from the refocusing of our Government Healthcare business in 2015.
|
•
|
$149 million decrease in pre-tax income before depreciation and amortization, gain on sales of businesses and assets, stock-based compensation and restructuring charges as well as the HE charge.
|
•
|
$128 million decrease from higher income tax payments primarily driven by the tax on the sale of the ITO business.
|
•
|
$105 million decrease due to the loss of cash flow associated with the ITO business, post-divestiture.
|
•
|
$167 million increase from accounts receivable primarily due to additional sales of accounts receivable under existing programs, select use of prompt pay discounts and lower revenues.
|
•
|
$36 million increase from lower spending for product software and up-front costs for outsourcing service contracts.
|
•
|
$22 million increase in accounts payable and accrued compensation primarily related to the timing our accounts payable.
|
•
|
$992 million decrease in proceeds from sales of businesses. The first twelve months of 2016 included a $52 million payment to Atos for final post-closing adjustments associated with the 2015 ITO divestiture. 2015 included $939 million of net proceeds from the sale of the ITO business
.
|
•
|
$3 million increase due to lower capital expenditures (including internal use software)
.
|
•
|
$196 million increase due to lower acquisitions
.
|
•
|
$285 million increase in net payments on related party notes receivable.
|
•
|
$11 million increase due to payment received on deferred comp investments.
|
•
|
$923 million increase in net proceeds from the sale of businesses, primarily the ITO business. Refer to Note - 4 Divestitures, in the Consolidated Financial Statements for additional information.
|
•
|
$109 million change from acquisitions. 2015 acquisitions include RSA Medical LLC for $141 million, Intellinex LLC for $28 million, InVentive Patient Access Solutions for $15 million and Healthy Communities Institute Corporation for $13 million. 2014 acquisitions include ISG Holdings, Inc. for $225 million, Invoco Holding GmbH for $54 million, Consilience Software, Inc. for $25 million.
|
•
|
$31 million due to lower capital expenditures (including internal use software) partly due to the sale of the ITO business.
|
•
|
$59 million charge due to higher net payments on related party notes receivable.
|
•
|
$2.1 billion increase primarily due to proceeds received on third party debt in 2016 ($1.9 billion) and payment of $250 million on Senior Notes in 2015
.
|
•
|
$1.0 billion decrease due to net payments on related party notes payable
.
|
•
|
$18 million decrease due to escrow related to the separation
|
•
|
$84 million increase due to net transfers from parent.
|
•
|
$636 million decrease due to net transfers to parent.
|
•
|
$242 million decrease from net debt activity. 2015 reflects payment of $250 million on Senior Notes and net payments of $15 million on capital leases. 2014 reflects net payments of $19 million on capital leases and net payments of $4 million on other debt.
|
•
|
$9 million decrease from contingent consideration payments for certain acquisitions in 2014.
|
(i)
|
Senior Secured Term Loan A (Term Loan A) due 2021 with an aggregate principal amount of
$700 million
;
|
(ii)
|
Senior Secured Term Loan B (Term Loan B) due 2023 with an aggregate principal amount of
$750 million
;
|
(iii)
|
Senior Revolving Credit Facility ("Revolving Credit Facility") due 2021 with an aggregate amount of
$750 million
. The Senior Credit Facilities includes access up to
$300 million
available for the issuance of letters of credit.
|
(in millions)
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
||||||||||||
Total debt, including capital lease obligations
(1)
|
|
$
|
28
|
|
|
$
|
72
|
|
|
$
|
67
|
|
|
$
|
79
|
|
|
$
|
528
|
|
|
$
|
1,223
|
|
Interest on debt
(2)
|
|
103
|
|
|
125
|
|
|
123
|
|
|
121
|
|
|
118
|
|
|
277
|
|
||||||
Minimum operating lease commitments
(3)
|
|
176
|
|
|
127
|
|
|
89
|
|
|
56
|
|
|
36
|
|
|
46
|
|
||||||
Defined benefit pension plans
|
|
10
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Estimated Purchase Commitments
(4)
|
|
82
|
|
|
75
|
|
|
70
|
|
|
37
|
|
|
1
|
|
|
26
|
|
||||||
Total
|
|
$
|
399
|
|
|
$
|
399
|
|
|
$
|
349
|
|
|
$
|
293
|
|
|
$
|
683
|
|
|
$
|
1,572
|
|
(1)
|
Total debt represents principal debt and capital leases. Refer to Note 10 - Debt in the Consolidated Financial Statements for additional information regarding debt.
|
(2)
|
Represents interest on debt. Refer to Note 10 - Debt in the Consolidated Financial Statements for additional information.
|
(3)
|
Refer to Note 6, Land, Buildings, Equipment and Software, Net in the Consolidated Financial Statements for additional information.
|
(4)
|
Other purchase commitments: We enter into other purchase commitments with vendors in the ordinary course of business. Our policy with respect to all purchase commitments is to record losses, if any, when they are probable and reasonably estimable. We currently do not have, nor do we anticipate, material loss contracts.
|
•
|
Operating leases in the normal course of business. The nature of these lease arrangements is discussed in Note 6 - Land, Buildings, Equipment and Software, Net in the Consolidated Financial Statements.
|
•
|
We have facilities, primarily in the U.S.and Europe that enable us to sell to third-parties certain accounts receivable without recourse. In most instances, a portion of the sales proceeds are held back by the purchaser and payment is deferred until collection of the related sold receivables. Refer to Note 5 - Accounts Receivables, Net in the Consolidated Financial Statements for further information regarding these facilities.
|
•
|
Amortization of intangible assets. The amortization of intangible assets is driven by acquisition activity, which can vary in size, nature and timing as compared to other companies within our industry and from period to period.
|
•
|
Restructuring and related costs. Restructuring and related costs include restructuring and asset impairment charges as well as costs associated with our strategic transformation program.
|
•
|
Separation costs. Separation costs are expenses incurred in connection with separation from Xerox Corporation into a separate, independent, publicly traded company. Separation costs primarily relate to third-party investment banking, accounting, legal, consulting and other similar types of services related to the separation transaction as well as costs associated with the operational separation of the two companies.
|
•
|
Other expenses, net, excluding third party interest expense. Other expenses, net includes losses (gains) on sales of businesses and assets, currency (gains) losses, net, litigation matters and all other expenses, net.
|
•
|
As defined above in Adjusted Net Income (Loss), Adjusted Earnings per Share, and Adjusted Effective Tax Rate:
|
◦
|
Amortization of intangible assets.
|
◦
|
Restructuring and related costs.
|
◦
|
Separation costs.
|
•
|
We also adjust Operating Income for:
|
◦
|
Related Party Interest. Includes interest payments to former parent.
|
◦
|
Other expenses, net. Including third party interest, losses (gains) on sales of businesses and assets, currency (gains) losses, net, litigation matters and all other expenses, net.
|
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
|
Year Ended December 31, 2014
|
||||||||||||||||||
(in millions; except per share amounts)
|
|
Net Income (Loss)
|
|
EPS
|
|
Net Income (Loss)
|
|
EPS
|
|
Net Income (Loss)
|
|
EPS
|
||||||||||||
Reported from continuing operations
|
|
$
|
(983
|
)
|
|
$
|
(4.85
|
)
|
|
$
|
(336
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
34
|
|
|
$
|
0.17
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Goodwill impairment
|
|
935
|
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|||||||||
Amortization of intangible assets
|
|
280
|
|
|
|
|
250
|
|
|
|
|
250
|
|
|
|
|||||||||
NY MMIS
|
|
161
|
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|||||||||
Restructuring and related costs
|
|
101
|
|
|
|
|
159
|
|
|
|
|
21
|
|
|
|
|||||||||
HE Charge
|
|
—
|
|
|
|
|
389
|
|
|
|
|
—
|
|
|
|
|||||||||
Separation costs
|
|
44
|
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|||||||||
Other expenses, net excluding third-party interest
(1)
|
|
20
|
|
|
|
|
30
|
|
|
|
|
34
|
|
|
|
|||||||||
Subtotal Adjustments
|
|
1,541
|
|
|
|
|
|
828
|
|
|
|
|
|
305
|
|
|
|
|
||||||
Less: Income tax adjustments
(2)
|
|
(335
|
)
|
|
|
|
(318
|
)
|
|
|
|
(114
|
)
|
|
|
|||||||||
Adjusted
|
|
$
|
223
|
|
|
$
|
1.06
|
|
|
$
|
174
|
|
|
$
|
0.83
|
|
|
$
|
225
|
|
|
$
|
1.07
|
|
Weighted average shares for adjusted EPS
(3)
|
|
|
|
210,774
|
|
|
|
|
210,774
|
|
|
|
|
210,774
|
|
(1)
|
Excludes third party interest expense of $14 million, $8 million and $11 million for the years ended December 31, 2016, 2015 and 2014, respectively.
|
(2)
|
Reflects the income tax (expense) benefit of the adjustments. Refer to Effective Tax Rate reconciliation below for details.
|
(3)
|
Average shares for the calculation of adjusted EPS include shares associated with our Series A convertible preferred stock and our stock compensation plan.
|
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
|
Year Ended December 31, 2014
|
|||||||||||||||||||||||||||
(in millions)
|
|
Pre-Tax
Income (loss)
|
|
Income Tax
(Benefit)Expense
|
|
Effective
Tax Rate
|
|
Pre-Tax
Income (loss)
|
|
Income Tax
(Benefit)Expense
|
|
Effective
Tax Rate
|
|
Pre-Tax
Income (loss)
|
|
Income Tax
(Benefit)Expense
|
|
Effective
Tax Rate
|
|||||||||||||||
Reported from continuing operations
|
|
$
|
(1,227
|
)
|
|
$
|
(244
|
)
|
|
19.9
|
%
|
|
$
|
(574
|
)
|
|
$
|
(238
|
)
|
|
41.5
|
%
|
|
$
|
10
|
|
|
$
|
(24
|
)
|
|
(240.0
|
)%
|
Non-GAAP Adjustments
(1)
|
|
1,541
|
|
|
335
|
|
|
|
|
828
|
|
|
318
|
|
|
|
|
305
|
|
|
114
|
|
|
|
|||||||||
Adjusted
(2)
|
|
$
|
314
|
|
|
$
|
91
|
|
|
29.0
|
%
|
|
$
|
254
|
|
|
$
|
80
|
|
|
31.5
|
%
|
|
$
|
315
|
|
|
$
|
90
|
|
|
28.6
|
%
|
(1)
|
Refer to Net Income (Loss) reconciliation for details of non-GAAP adjustments.
|
(2)
|
The tax impact of Adjusted Pre-tax income from continuing operations is calculated under the same accounting principles applied to the 'As Reported' Pre-tax income under ASC 740, which employs an annual effective tax rate method to the results.
|
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
|
Year Ended December 31, 2014
|
|||||||||||||||||||||||||||
(in millions)
|
|
Profit (Loss)
|
|
Revenue
|
|
Margin
|
|
Profit (Loss)
|
|
Revenue
|
|
Margin
|
|
Profit (Loss)
|
|
Revenue
|
|
Margin
|
|||||||||||||||
Reported Pre-tax (Loss) Income
from Continuing Operations
|
|
$
|
(1,227
|
)
|
|
$
|
6,408
|
|
|
(19.1
|
)%
|
|
$
|
(574
|
)
|
|
$
|
6,662
|
|
|
(8.6
|
)%
|
|
$
|
10
|
|
|
$
|
6,938
|
|
|
0.1
|
%
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Goodwill impairment
|
|
935
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
—
|
|
|
|
|
|
||||||||||||
Amortization of intangible assets
|
|
280
|
|
|
|
|
|
|
250
|
|
|
|
|
|
|
250
|
|
|
|
|
|
||||||||||||
NY MMIS
|
|
161
|
|
|
83
|
|
|
|
|
—
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|||||||||||
Restructuring and related charges
|
|
101
|
|
|
|
|
|
|
159
|
|
|
|
|
|
|
21
|
|
|
|
|
|
||||||||||||
Separation costs
|
|
44
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
—
|
|
|
|
|
|
||||||||||||
Related party interest
|
|
26
|
|
|
|
|
|
|
61
|
|
|
|
|
|
|
107
|
|
|
|
|
|
||||||||||||
HE Charge
|
|
—
|
|
|
|
|
|
|
389
|
|
|
116
|
|
|
|
|
—
|
|
|
|
|
|
|||||||||||
Other expenses, net
|
|
34
|
|
|
|
|
|
|
38
|
|
|
|
|
|
|
45
|
|
|
|
|
|
||||||||||||
Adjusted Operating Income / Margin
|
|
$
|
354
|
|
|
$
|
6,491
|
|
|
5.5
|
%
|
|
$
|
323
|
|
|
$
|
6,778
|
|
|
4.8
|
%
|
|
$
|
433
|
|
|
$
|
6,938
|
|
|
6.2
|
%
|
|
|
Year Ended December 31,
|
||||||
(in millions)
|
|
2016
|
|
2015
|
||||
Revenue As Reported from Continuing Operations
|
|
$
|
6,408
|
|
|
$
|
6,662
|
|
NY MMIS
|
|
83
|
|
|
—
|
|
||
HE charge
|
|
—
|
|
|
116
|
|
||
Revenue Adjusted
|
|
$
|
6,491
|
|
|
$
|
6,778
|
|
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
||||||||||||||||||||
(in millions)
|
|
As Reported from Continuing Operations
|
|
NY MMIS
|
|
Adjusted
|
|
As Reported from Continuing Operations
|
|
HE Charge
|
|
Adjusted
|
||||||||||||
Other Segment Revenue
|
|
$
|
301
|
|
|
$
|
83
|
|
|
$
|
384
|
|
|
$
|
289
|
|
|
$
|
116
|
|
|
$
|
405
|
|
Other Segment Loss
|
|
(245
|
)
|
|
161
|
|
|
(84
|
)
|
|
(489
|
)
|
|
389
|
|
|
(100
|
)
|
||||||
Other Segment Margin
|
|
n/a
|
|
|
|
|
(21.9
|
)%
|
|
n/a
|
|
|
|
|
(24.7
|
)%
|
|
|
Year Ended December 31, 2016
|
|
Year Ended December 31, 2015
|
||||||||||||||
(in millions)
|
|
Gross Margin
|
|
R&D as % of Revenue
|
|
SAG as % of Revenue
|
|
Gross Margin
|
|
R&D as % of Revenue
|
|
SAG as % of Revenue
|
||||||
As Reported from Continuing Operations
|
|
14.2
|
%
|
|
0.5
|
%
|
|
10.7
|
%
|
|
10.3
|
%
|
|
0.8
|
%
|
|
10.5
|
%
|
Adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
NY MMIS charge
|
|
2.3
|
|
|
—
|
|
|
(0.1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
HE charge
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5.5
|
|
|
—
|
|
|
(0.2
|
)
|
Adjusted
|
|
16.5
|
%
|
|
0.5
|
%
|
|
10.6
|
%
|
|
15.8
|
%
|
|
0.8
|
%
|
|
10.3
|
%
|
/s/ P
RICEWATERHOUSE
C
OOPERS
LLP
|
Dallas, Texas
|
March 10, 2017
|
/s/ A
SHOK
V
EMURI
|
|
/s/ B
RIAN
W
EBB
-W
ALSH
|
|
/s/ J
AY
T. C
HU
|
Chief Executive Officer
|
|
Chief Financial Officer
|
|
Chief Accounting Officer
|
|
|
Year Ended December 31,
|
||||||||||
(in millions, except per-share data)
|
|
2016
|
|
2015
|
|
2014
|
||||||
Revenues
|
|
|
|
|
|
|
||||||
Outsourcing
|
|
$
|
6,358
|
|
|
$
|
6,609
|
|
|
$
|
6,884
|
|
Related party
|
|
50
|
|
|
53
|
|
|
54
|
|
|||
Total Revenues
|
|
6,408
|
|
|
6,662
|
|
|
6,938
|
|
|||
Costs and Expenses
|
|
|
|
|
|
|
||||||
Cost of outsourcing
|
|
5,462
|
|
|
5,937
|
|
|
5,758
|
|
|||
Related party cost of services
|
|
36
|
|
|
40
|
|
|
42
|
|
|||
Research and development
|
|
31
|
|
|
52
|
|
|
46
|
|
|||
Selling, administrative and general
|
|
686
|
|
|
699
|
|
|
659
|
|
|||
Restructuring and related costs
|
|
101
|
|
|
159
|
|
|
21
|
|
|||
Amortization of intangible assets
|
|
280
|
|
|
250
|
|
|
250
|
|
|||
Goodwill impairment
|
|
935
|
|
|
—
|
|
|
—
|
|
|||
Separation costs
|
|
44
|
|
|
—
|
|
|
—
|
|
|||
Related party interest
|
|
26
|
|
|
61
|
|
|
107
|
|
|||
Other expenses, net
|
|
34
|
|
|
38
|
|
|
45
|
|
|||
Total Costs and Expenses
|
|
7,635
|
|
|
7,236
|
|
|
6,928
|
|
|||
(Loss) Income Before Income Taxes
|
|
(1,227
|
)
|
|
(574
|
)
|
|
10
|
|
|||
Income tax benefit
|
|
(244
|
)
|
|
(238
|
)
|
|
(24
|
)
|
|||
(Loss) Income from Continuing Operations
|
|
(983
|
)
|
|
(336
|
)
|
|
34
|
|
|||
Loss from discontinued operations, net of tax
|
|
—
|
|
|
(78
|
)
|
|
(115
|
)
|
|||
Net Loss
|
|
$
|
(983
|
)
|
|
$
|
(414
|
)
|
|
$
|
(81
|
)
|
|
|
|
|
|
|
|
||||||
Basic Earnings (Loss) per Share:
|
|
|
|
|
|
|
||||||
Continuing operations
|
|
$
|
(4.85
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
0.17
|
|
Discontinued operations
|
|
—
|
|
|
(0.39
|
)
|
|
(0.57
|
)
|
|||
Total Basic Earnings (Loss) per Share
|
|
$
|
(4.85
|
)
|
|
$
|
(2.04
|
)
|
|
$
|
(0.40
|
)
|
Diluted Earnings (Loss) per Share:
|
|
|
|
|
|
|
||||||
Continuing operations
|
|
$
|
(4.85
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
0.17
|
|
Discontinued operations
|
|
—
|
|
|
(0.39
|
)
|
|
(0.57
|
)
|
|||
Total Diluted Earnings (Loss) per Share
|
|
$
|
(4.85
|
)
|
|
$
|
(2.04
|
)
|
|
$
|
(0.40
|
)
|
|
|
Year Ended December 31,
|
||||||||||
(in millions)
|
|
2016
|
|
2015
|
|
2014
|
||||||
Net Loss
|
|
$
|
(983
|
)
|
|
$
|
(414
|
)
|
|
$
|
(81
|
)
|
|
|
|
|
|
|
|
||||||
Other Comprehensive Loss, Net
(1)
:
|
|
|
|
|
|
|
||||||
Translation adjustments, net
|
|
$
|
(135
|
)
|
|
$
|
(60
|
)
|
|
$
|
(44
|
)
|
Unrealized gain (losses), net
|
|
—
|
|
|
1
|
|
|
(2
|
)
|
|||
Changes in defined benefit plans, net
|
|
(20
|
)
|
|
7
|
|
|
(25
|
)
|
|||
Other Comprehensive Loss, Net
|
|
(155
|
)
|
|
(52
|
)
|
|
(71
|
)
|
|||
|
|
|
|
|
|
|
||||||
Comprehensive Loss, Net
|
|
$
|
(1,138
|
)
|
|
$
|
(466
|
)
|
|
$
|
(152
|
)
|
(1)
|
Refer to Note 18 - Other Comprehensive Loss for gross components of Other Comprehensive Loss, reclassification adjustments out of Accumulated Other Comprehensive Loss and related tax effects.
|
|
|
December 31,
|
||||||
(in millions, except share data in thousands)
|
|
2016
|
|
2015
|
||||
Assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
390
|
|
|
$
|
140
|
|
Accounts receivable, net
|
|
1,286
|
|
|
1,246
|
|
||
Related party notes receivable
|
|
—
|
|
|
248
|
|
||
Other current assets
|
|
241
|
|
|
240
|
|
||
Total current assets
|
|
1,917
|
|
|
1,874
|
|
||
Land, buildings and equipment, net
|
|
283
|
|
|
280
|
|
||
Intangible assets, net
|
|
1,144
|
|
|
1,425
|
|
||
Goodwill
|
|
3,889
|
|
|
4,872
|
|
||
Other long-term assets
|
|
476
|
|
|
607
|
|
||
Total Assets
|
|
$
|
7,709
|
|
|
$
|
9,058
|
|
Liabilities and Equity
|
|
|
|
|
||||
Short-term debt and current portion of long-term debt
|
|
$
|
28
|
|
|
$
|
24
|
|
Related party notes payable
|
|
—
|
|
|
1,132
|
|
||
Accounts payable
|
|
164
|
|
|
264
|
|
||
Accrued compensation and benefits costs
|
|
269
|
|
|
249
|
|
||
Unearned income
|
|
206
|
|
|
227
|
|
||
Net payable to former parent company
|
|
124
|
|
|
—
|
|
||
Other current liabilities
|
|
611
|
|
|
845
|
|
||
Total current liabilities
|
|
1,402
|
|
|
2,741
|
|
||
Long-term debt
|
|
1,913
|
|
|
37
|
|
||
Pension and other benefit liabilities
|
|
172
|
|
|
153
|
|
||
Deferred taxes
|
|
619
|
|
|
764
|
|
||
Other long-term liabilities
|
|
173
|
|
|
201
|
|
||
Total Liabilities
|
|
4,279
|
|
|
3,896
|
|
||
|
|
|
|
|
||||
Commitments and contingencies (See Note 15)
|
|
|
|
|
|
|
||
Series A Convertible Preferred Stock
|
|
142
|
|
|
—
|
|
||
|
|
|
|
|
||||
Common stock
|
|
2
|
|
|
—
|
|
||
Additional paid-in capital
|
|
3,812
|
|
|
—
|
|
||
Former parent company investment
|
|
—
|
|
|
5,343
|
|
||
Accumulated other comprehensive loss
|
|
(526
|
)
|
|
(181
|
)
|
||
Total Equity
|
|
3,288
|
|
|
5,162
|
|
||
Total Liabilities and Equity
|
|
$
|
7,709
|
|
|
$
|
9,058
|
|
|
|
|
|
|
||||
Shares of common stock issued and outstanding
|
|
202,875
|
|
|
—
|
|
||
Shares of Series A convertible preferred stock issued and outstanding
|
|
120
|
|
|
—
|
|
|
|
Year Ended December 31,
|
||||||||||
(in millions)
|
|
2016
|
|
2015
|
|
2014
|
||||||
Cash Flows from Operating Activities:
|
|
|
|
|
|
|
||||||
Net loss
|
|
$
|
(983
|
)
|
|
$
|
(414
|
)
|
|
$
|
(81
|
)
|
Adjustments required to reconcile net income to cash flows from operating activities:
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
613
|
|
|
600
|
|
|
787
|
|
|||
Goodwill impairment
|
|
935
|
|
|
—
|
|
|
—
|
|
|||
Provision for receivables
|
|
4
|
|
|
4
|
|
|
3
|
|
|||
Deferred tax benefit
|
|
(160
|
)
|
|
(115
|
)
|
|
(123
|
)
|
|||
Net loss on sales of businesses and assets
|
|
2
|
|
|
100
|
|
|
183
|
|
|||
Stock-based compensation
|
|
23
|
|
|
19
|
|
|
28
|
|
|||
Restructuring and asset impairment charges
|
|
73
|
|
|
159
|
|
|
23
|
|
|||
Payments for restructurings
|
|
(46
|
)
|
|
(19
|
)
|
|
(23
|
)
|
|||
Contributions to defined benefit pension plans
|
|
(6
|
)
|
|
(8
|
)
|
|
(15
|
)
|
|||
(Increase) decrease in accounts receivable
|
|
(27
|
)
|
|
239
|
|
|
(44
|
)
|
|||
Increase in other current and long-term assets
|
|
(90
|
)
|
|
(86
|
)
|
|
(168
|
)
|
|||
(Decrease) increase in accounts payable and accrued compensation
|
|
(60
|
)
|
|
22
|
|
|
—
|
|
|||
(Decrease) increase in other current and long-term liabilities
|
|
(210
|
)
|
|
228
|
|
|
57
|
|
|||
Net change in income tax assets and liabilities
|
|
39
|
|
|
(236
|
)
|
|
38
|
|
|||
Other operating, net
|
|
1
|
|
|
—
|
|
|
—
|
|
|||
Net cash provided by operating activities
|
|
108
|
|
|
493
|
|
|
665
|
|
|||
Cash Flows from Investing Activities:
|
|
|
|
|
|
|
||||||
Cost of additions to land, buildings and equipment
(1)
|
|
(149
|
)
|
|
(158
|
)
|
|
(189
|
)
|
|||
Cost of additions to internal use software
|
|
(39
|
)
|
|
(27
|
)
|
|
(27
|
)
|
|||
Proceeds from sale of businesses, net of adjustments
|
|
(53
|
)
|
|
939
|
|
|
16
|
|
|||
Acquisitions, net of cash acquired
|
|
(1
|
)
|
|
(197
|
)
|
|
(306
|
)
|
|||
Proceeds from investments
|
|
11
|
|
|
—
|
|
|
—
|
|
|||
Net proceeds (payments) on related party notes receivable
|
|
248
|
|
|
(37
|
)
|
|
22
|
|
|||
Other investing, net
|
|
(1
|
)
|
|
2
|
|
|
(4
|
)
|
|||
Net cash provided by (used in) investing activities
|
|
16
|
|
|
522
|
|
|
(488
|
)
|
|||
Cash Flows from Financing Activities:
|
|
|
|
|
|
|
||||||
Proceeds on long term debt, net of issuance costs
(1)
|
|
1,902
|
|
|
28
|
|
|
53
|
|
|||
Payments on debt
|
|
(32
|
)
|
|
(293
|
)
|
|
(76
|
)
|
|||
Net payments on related party notes payable
|
|
(1,132
|
)
|
|
(91
|
)
|
|
(90
|
)
|
|||
Transfers to former parent
|
|
(588
|
)
|
|
(672
|
)
|
|
(36
|
)
|
|||
Restricted cash - related party
|
|
(18
|
)
|
|
—
|
|
|
—
|
|
|||
Excess tax benefits from stock-based compensation
|
|
—
|
|
|
6
|
|
|
10
|
|
|||
Other financing
|
|
—
|
|
|
(1
|
)
|
|
(10
|
)
|
|||
Net cash provided by (used in) financing activities
|
|
132
|
|
|
(1,023
|
)
|
|
(149
|
)
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
|
(6
|
)
|
|
(11
|
)
|
|
(8
|
)
|
|||
Increase (decrease) in cash and cash equivalents
|
|
250
|
|
|
(19
|
)
|
|
20
|
|
|||
Cash and cash equivalents at beginning of Year
|
|
140
|
|
|
159
|
|
|
139
|
|
|||
Cash and Cash Equivalents at End of Year
|
|
$
|
390
|
|
|
$
|
140
|
|
|
$
|
159
|
|
(1)
|
Adjusted to exclude the initiation of capital leases of
$8
and
$59
in 2015 and 2014, respectively as the initiation of capital leases is a non-cash activity. Refer to Note 1 - Basis of Presentation and Summary of Significant Accounting Policies for additional information.
|
(in millions)
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
AOCL
(1)
|
|
Former Parent Company Investment
|
|
Conduent
Shareholders’
Equity
|
||||||||||
Balance at December 31, 2013
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(58
|
)
|
|
$
|
5,637
|
|
|
$
|
5,579
|
|
Comprehensive loss, net
|
—
|
|
|
—
|
|
|
(71
|
)
|
|
(81
|
)
|
|
(152
|
)
|
|||||
Net transfers to former parent
|
—
|
|
|
—
|
|
|
—
|
|
|
(16
|
)
|
|
(16
|
)
|
|||||
Balance at December 31, 2014
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(129
|
)
|
|
$
|
5,540
|
|
|
$
|
5,411
|
|
Comprehensive loss, net
|
—
|
|
|
—
|
|
|
(52
|
)
|
|
(414
|
)
|
|
(466
|
)
|
|||||
Net transfers from former parent
|
—
|
|
|
—
|
|
|
—
|
|
|
217
|
|
|
217
|
|
|||||
Balance at December 31, 2015
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(181
|
)
|
|
$
|
5,343
|
|
|
$
|
5,162
|
|
Comprehensive loss, net
|
—
|
|
|
—
|
|
|
(155
|
)
|
|
(983
|
)
|
|
(1,138
|
)
|
|||||
Series A preferred stock transfer
|
—
|
|
|
—
|
|
|
—
|
|
|
(142
|
)
|
|
(142
|
)
|
|||||
Capitalization of Company
|
2
|
|
|
3,812
|
|
|
|
|
(3,814
|
)
|
|
—
|
|
||||||
Net transfers to former parent
|
—
|
|
|
—
|
|
|
(190
|
)
|
|
(404
|
)
|
|
(594
|
)
|
|||||
Balance at December 31, 2016
|
$
|
2
|
|
|
$
|
3,812
|
|
|
$
|
(526
|
)
|
|
$
|
—
|
|
|
$
|
3,288
|
|
(1)
|
AOCL - Accumulated other comprehensive loss.
|
|
|
Year Ended December 31,
|
||||||||||
Expense/(Income)
|
|
2016
|
|
2015
|
|
2014
|
||||||
Corporate allocations
(1)
|
|
$
|
165
|
|
|
$
|
170
|
|
|
$
|
175
|
|
Provisions for restructuring and asset impairments - continuing operations
|
|
73
|
|
|
159
|
|
|
21
|
|
|||
Provisions for restructuring and asset impairments - discontinued operations
|
|
—
|
|
|
—
|
|
|
2
|
|
|||
Provision for receivables
|
|
4
|
|
|
4
|
|
|
3
|
|
|||
Provisions for litigation and regulatory matters
|
|
40
|
|
|
18
|
|
|
38
|
|
|||
Depreciation of buildings and equipment
(2)
|
|
130
|
|
|
126
|
|
|
145
|
|
|||
Amortization of internal use software
(2)
|
|
49
|
|
|
51
|
|
|
52
|
|
|||
Amortization of product software
|
|
61
|
|
|
65
|
|
|
58
|
|
|||
Amortization of acquired intangible assets
(2)
|
|
280
|
|
|
250
|
|
|
250
|
|
|||
Amortization of customer contract costs
(2)
|
|
93
|
|
|
108
|
|
|
122
|
|
|||
Income tax (benefit) expense - continuing operations
|
|
(244
|
)
|
|
(238
|
)
|
|
(24
|
)
|
|||
Income tax expense - discontinued operations
|
|
—
|
|
|
81
|
|
|
7
|
|
(1)
|
Refer to Note 20 - Related Party and Former Parent Investment.
|
(2)
|
Excludes amounts related to our ITO business, which was reported as a discontinued operation through its date of sale on June 30, 2015. Refer to Note 4 - Divestitures for additional information regarding this sale.
|
•
|
Accounting Changes and Error Corrections
(Topic 250):
ASU 2017-03
, Accounting Changes and Error Corrections (Topic 250) and Investments-Equity Method and Joint Ventures (Topic 323). Transition guidance included in certain issued but not yet adopted ASUs was updated to reflect this amendment.
|
•
|
Financial Instruments
:
ASU 2016-01
,
Financial Instruments - Recognition and Measurement of Financial Instruments and Financial Liabilities,
which is effective for our fiscal year beginning January 1, 2018.
|
•
|
Inventory:
ASU 2015-11
,
Simplifying the Subsequent Measurement of Inventory,
which is effective for our fiscal year beginning January 1, 2017.
|
•
|
Fair Value Measurements
:
ASU 2015-07
,
Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or its Equivalent)
, which was effective for our fiscal year beginning January 1,
2016.
|
•
|
Stock Compensation
:
ASU 2014-12
,
Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period,
which was effective for our fiscal year beginning January 1, 2016.
|
•
|
Business Combinations:
ASU 2015-16
,
Accounting for Measurement Period Adjustments in a Business Combination
, which was effective for our fiscal year beginning January 1, 2016.
|
•
|
Intangibles - Goodwill and Other - Internal Use Software:
ASU 2015-05
,
Intangibles-Goodwill and Other-Internal Use Software - Customer's Accounting for Fees Paid in a Cloud Computing Arrangement,
which was effective for our fiscal year beginning January 1, 2016.
|
•
|
Consolidation:
ASU 2015-02
,
Consolidation (Topic 810): Amendments to the Consolidation Analysis
. This update was effective for our fiscal year beginning January 1, 2016 with early adoption permitted, and is applied on a modified retrospective basis.
|
•
|
Income Statement:
ASU 2015-01,
Income Statement - Extraordinary and Unusual Items (Subtopic 225-20) - Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items
. The standard primarily involves presentation and disclosure.
|
•
|
Derivatives and Hedging
:
ASU 2016-06
,
Contingent Put and Call Options in Debt Instruments
, which is effective for our fiscal year beginning January 1, 2017 with early adoption permitted.
|
•
|
Derivatives and Hedging
:
A
SU 2016-05
,
Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships
, which is effective for our fiscal year beginning January 1, 2017 with early adoption permitted.
|
•
|
Derivatives and Hedging:
ASU 2014-16
,
Derivatives and Hedging (Topic 815) - Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity,
which
was effective for our fiscal year beginning January 1, 2016.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Set-up/transition and inducement expenditures
|
|
$
|
63
|
|
|
$
|
65
|
|
|
$
|
81
|
|
|
|
Year Ended December 31,
|
||||
|
|
2016
|
|
2015
|
||
Capitalized customer contract costs
(1)
|
|
137
|
|
|
170
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
||||||||||||
$
|
58
|
|
|
$
|
29
|
|
|
$
|
16
|
|
|
$
|
8
|
|
|
$
|
5
|
|
|
$
|
21
|
|
•
|
The delivered item(s) has value to the customer on a stand-alone basis; and
|
•
|
If the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in our control.
|
•
|
Commercial Industries
|
•
|
Healthcare
|
•
|
Public Sector
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
Commercial Industries
|
|
Healthcare
|
|
Public Sector
|
|
Other
(1)
|
|
Total
|
||||||||||
2016
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenue
|
|
$
|
2,622
|
|
|
$
|
1,681
|
|
|
$
|
1,727
|
|
|
$
|
328
|
|
|
$
|
6,358
|
|
Related party revenue
|
|
48
|
|
|
2
|
|
|
1
|
|
|
(1
|
)
|
|
50
|
|
|||||
Inter-segment revenue
|
|
20
|
|
|
3
|
|
|
3
|
|
|
(26
|
)
|
|
—
|
|
|||||
Total Segment Revenue
|
|
$
|
2,690
|
|
|
$
|
1,686
|
|
|
$
|
1,731
|
|
|
$
|
301
|
|
|
$
|
6,408
|
|
Depreciation and amortization
(2)
|
|
$
|
117
|
|
|
$
|
66
|
|
|
$
|
81
|
|
|
$
|
69
|
|
|
$
|
333
|
|
Segment profit (loss)
|
|
59
|
|
|
159
|
|
|
223
|
|
|
(245
|
)
|
|
196
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2015
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenue
|
|
$
|
2,822
|
|
|
$
|
1,746
|
|
|
$
|
1,723
|
|
|
$
|
318
|
|
|
$
|
6,609
|
|
Related party revenue
|
|
51
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
53
|
|
|||||
Inter-segment revenue
|
|
23
|
|
|
2
|
|
|
4
|
|
|
(29
|
)
|
|
—
|
|
|||||
Total Segment Revenue
|
|
$
|
2,896
|
|
|
$
|
1,750
|
|
|
$
|
1,727
|
|
|
$
|
289
|
|
|
$
|
6,662
|
|
Depreciation and amortization
(2)
|
|
$
|
119
|
|
|
$
|
64
|
|
|
$
|
84
|
|
|
$
|
83
|
|
|
$
|
350
|
|
Segment profit (loss)
|
|
69
|
|
|
157
|
|
|
200
|
|
|
(489
|
)
|
|
(63
|
)
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2014
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenue
|
|
$
|
2,881
|
|
|
$
|
1,738
|
|
|
$
|
1,763
|
|
|
$
|
502
|
|
|
$
|
6,884
|
|
Related party revenue
|
|
51
|
|
|
3
|
|
|
—
|
|
|
—
|
|
|
54
|
|
|||||
Inter-segment revenue
|
|
21
|
|
|
2
|
|
|
4
|
|
|
(27
|
)
|
|
—
|
|
|||||
Total Segment Revenue
|
|
$
|
2,953
|
|
|
$
|
1,743
|
|
|
$
|
1,767
|
|
|
$
|
475
|
|
|
$
|
6,938
|
|
Depreciation and amortization
(2)
|
|
$
|
126
|
|
|
$
|
101
|
|
|
$
|
79
|
|
|
$
|
71
|
|
|
$
|
377
|
|
Segment profit (loss)
|
|
152
|
|
|
138
|
|
|
206
|
|
|
(49
|
)
|
|
447
|
|
(1)
|
Other results for 2016 includes a charge of
$161
related to our NY MMIS project.
$83
was recorded as a reduction to revenue and the remainder of
$78
was recorded to Cost of outsourcing. Other results for 2015 include a charge of
$389
related to our Health Enterprise platform implementations in California and Montana.
$116
of the charge was recorded as a reduction to revenues and the remainder of
$273
was recorded to Cost of outsourcing.
|
(2)
|
Depreciation and amortization excludes amortization of intangible assets - see reconciliation below for amounts - as well as depreciation and amortization associated with Discontinued Operations. Refer to Note 4 - Divestitures for amounts.
|
(1)
|
Restructuring and asset impairment charges were
$73
,
$159
, and
$21
for each of the three years ended December 31,
2016
,
2015
and
2014
, respectively and Strategic transformation costs were
$28
for the year ended December 31, 2016.
|
(2)
|
Business transformation costs represent incremental costs incurred directly in support of our business transformation and restructuring initiatives such as compensation costs for overlapping staff, consulting costs and training costs.
|
|
|
Revenues
|
|
Long-Lived Assets
(1)
|
||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2016
|
|
2015
|
||||||||||
United States
|
|
$
|
5,686
|
|
|
$
|
5,849
|
|
|
$
|
5,923
|
|
|
$
|
325
|
|
|
$
|
393
|
|
Europe
|
|
547
|
|
|
616
|
|
|
786
|
|
|
38
|
|
|
42
|
|
|||||
Other areas
|
|
175
|
|
|
197
|
|
|
229
|
|
|
73
|
|
|
71
|
|
|||||
Total Revenues and Long-Lived Assets
|
|
$
|
6,408
|
|
|
$
|
6,662
|
|
|
$
|
6,938
|
|
|
$
|
436
|
|
|
$
|
506
|
|
(1)
|
Long-lived assets are comprised of (i) Land, buildings and equipment, net, (ii) Internal use software, net and (iii) Product software, net.
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2015
|
|
2014
|
||||||||||||||||
|
|
ITO
|
|
Total
|
|
ITO
|
|
TMS
|
|
Total
|
||||||||||
Revenues
|
|
$
|
619
|
|
|
$
|
619
|
|
|
$
|
1,320
|
|
|
$
|
18
|
|
|
$
|
1,338
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Income (loss) from operations
(1),(2)
|
|
$
|
104
|
|
|
$
|
104
|
|
|
$
|
74
|
|
|
$
|
—
|
|
|
$
|
74
|
|
Loss on disposal
|
|
(101
|
)
|
|
(101
|
)
|
|
(181
|
)
|
|
(1
|
)
|
|
(182
|
)
|
|||||
Net income (loss) before income taxes
|
|
$
|
3
|
|
|
$
|
3
|
|
|
$
|
(107
|
)
|
|
$
|
(1
|
)
|
|
$
|
(108
|
)
|
Income tax expense
|
|
(81
|
)
|
|
(81
|
)
|
|
(5
|
)
|
|
(2
|
)
|
|
(7
|
)
|
|||||
Loss from discontinued operations, net of tax
|
|
$
|
(78
|
)
|
|
$
|
(78
|
)
|
|
$
|
(112
|
)
|
|
$
|
(3
|
)
|
|
$
|
(115
|
)
|
(1)
|
ITO income from operations for the year ended December 31, 2015, excludes approximately $
80
of depreciation and amortization expense (including $
14
for intangible amortization) since the business was held for sale.
|
(2)
|
ITO Income from operations for the year ended December 31, 2014 includes approximately $
160
of depreciation and amortization expense (including
$27
for intangible amortization).
|
|
|
Year Ended December 31,
|
||||||
|
|
2015
|
|
2014
|
||||
Expenses:
|
|
|
|
|
||||
Depreciation of buildings and equipment
(1)
|
|
$
|
—
|
|
|
$
|
98
|
|
Amortization of internal use software
(1)
|
|
—
|
|
|
9
|
|
||
Amortization of acquired intangible assets
(1)
|
|
—
|
|
|
27
|
|
||
Amortization of customer contract costs
(1)
|
|
—
|
|
|
26
|
|
||
Operating lease rent expense
|
|
130
|
|
|
258
|
|
||
Defined contribution plans
|
|
4
|
|
|
8
|
|
||
Interest expense
(2)
|
|
2
|
|
|
4
|
|
||
|
|
|
|
|
||||
Expenditures:
|
|
|
|
|
||||
Cost of additions to land, buildings and equipment
|
|
$
|
41
|
|
|
$
|
105
|
|
Cost of additions to internal use software
|
|
1
|
|
|
2
|
|
||
Customer-related deferred set-up/transition and inducement costs
|
|
10
|
|
|
26
|
|
(1)
|
ITO income from operations for the year ended December 31, 2015, excludes approximately $
80
of depreciation and amortization expense (including $
14
for intangible amortization) since the business was held for sale.
|
(2)
|
Interest expense is related to capital lease obligations, which were assumed by the purchaser of the ITO business.
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Amounts billed or billable
|
|
$
|
1,014
|
|
|
$
|
963
|
|
Unbilled amounts
|
|
279
|
|
|
289
|
|
||
Allowance for doubtful accounts
|
|
(7
|
)
|
|
(6
|
)
|
||
Accounts Receivable, Net
|
|
$
|
1,286
|
|
|
$
|
1,246
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Accounts receivable sales
|
|
$
|
250
|
|
|
$
|
325
|
|
|
$
|
343
|
|
Estimated increase (decrease) to operating cash flows
(1)
|
|
(136
|
)
|
|
58
|
|
|
(4
|
)
|
(1)
|
Represents the difference between current and prior year fourth quarter receivable sales adjusted for the effects of: (i) deferred proceeds, (ii) collections prior to the end of the year and (iii) currency.
|
|
|
Estimated Useful Lives
|
|
December 31,
|
||||||
|
|
(Years)
|
|
2016
|
|
2015
|
||||
Land
|
|
|
|
$
|
10
|
|
|
$
|
10
|
|
Building and building equipment
|
|
25 to 50
|
|
20
|
|
|
28
|
|
||
Leasehold improvements
|
|
Varies
|
|
236
|
|
|
208
|
|
||
Office furniture and equipment
|
|
3 to 15
|
|
719
|
|
|
689
|
|
||
Other
|
|
4 to 20
|
|
1
|
|
|
3
|
|
||
Construction in progress
|
|
|
|
54
|
|
|
26
|
|
||
Subtotal
|
|
|
|
1,040
|
|
|
964
|
|
||
Accumulated depreciation
|
|
|
|
(757
|
)
|
|
(684
|
)
|
||
Land, Buildings and Equipment, Net
|
|
|
|
$
|
283
|
|
|
$
|
280
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Depreciation expense
|
|
$
|
130
|
|
|
$
|
126
|
|
|
$
|
145
|
|
Operating lease rent expense
|
|
$
|
378
|
|
|
$
|
389
|
|
|
$
|
385
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
||||||||||||
$
|
176
|
|
|
$
|
127
|
|
|
$
|
89
|
|
|
$
|
56
|
|
|
$
|
36
|
|
|
$
|
46
|
|
|
|
Year Ended December 31,
|
||||||||||
Additions to:
|
|
2016
|
|
2015
|
|
2014
|
||||||
Internal use software
|
|
$
|
39
|
|
|
$
|
27
|
|
|
$
|
27
|
|
Product software
|
|
10
|
|
|
19
|
|
|
23
|
|
|
|
December 31,
|
||||||
Capitalized Costs, Net
|
|
2016
|
|
2015
|
||||
Internal use software
|
|
$
|
115
|
|
|
$
|
119
|
|
Product software
|
|
38
|
|
|
107
|
|
(1)
|
Balances included in Other Long-term assets, refer to Note 9 - Supplementary Financial Information for additional information.
|
|
|
Commercial Industries
|
|
Healthcare
|
|
Public Sector
|
|
Total
|
||||||||
Balance at December 31, 2014
|
|
$
|
1,939
|
|
|
$
|
1,123
|
|
|
$
|
1,722
|
|
|
$
|
4,784
|
|
Foreign currency translation
|
|
(30
|
)
|
|
(9
|
)
|
|
(18
|
)
|
|
(57
|
)
|
||||
Acquisitions:
|
|
|
|
|
|
|
|
|
||||||||
RSA Medical
|
|
—
|
|
|
107
|
|
|
—
|
|
|
107
|
|
||||
Intellinex
|
|
19
|
|
|
—
|
|
|
—
|
|
|
19
|
|
||||
Consilience
|
|
—
|
|
|
12
|
|
|
—
|
|
|
12
|
|
||||
Reclassifications
(1)
|
|
(61
|
)
|
|
61
|
|
|
—
|
|
|
—
|
|
||||
Other
|
|
—
|
|
|
7
|
|
|
—
|
|
|
7
|
|
||||
Balance at December 31, 2015
|
|
$
|
1,867
|
|
|
$
|
1,301
|
|
|
$
|
1,704
|
|
|
$
|
4,872
|
|
Foreign currency translation
|
|
(22
|
)
|
|
(8
|
)
|
|
(14
|
)
|
|
(44
|
)
|
||||
Acquisitions: RSA Medical
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
||||
Disposition: Nuova Karel Solutions
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
||||
Impairment
|
|
(935
|
)
|
|
—
|
|
|
—
|
|
|
(935
|
)
|
||||
Balance at December 31, 2016
|
|
$
|
908
|
|
|
$
|
1,291
|
|
|
$
|
1,690
|
|
|
$
|
3,889
|
|
(1)
|
Represents the reclassification of certain Healthcare contracts from our Commercial Industries segment to our Healthcare segment.
|
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
|
|
Weighted Average
Amortization
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
Amount
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
Amount
|
||||||||||||
Customer relationships
|
|
12 years
|
|
$
|
2,924
|
|
|
$
|
1,788
|
|
|
$
|
1,136
|
|
|
$
|
2,927
|
|
|
$
|
1,528
|
|
|
$
|
1,399
|
|
Trademarks
|
|
9 years
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22
|
|
|
4
|
|
|
18
|
|
||||||
Technology, patents and non-compete
|
|
4 years
|
|
11
|
|
|
3
|
|
|
8
|
|
|
13
|
|
|
5
|
|
|
8
|
|
||||||
Total Intangible Assets
|
|
|
|
$
|
2,935
|
|
|
$
|
1,791
|
|
|
$
|
1,144
|
|
|
$
|
2,962
|
|
|
$
|
1,537
|
|
|
$
|
1,425
|
|
|
|
Severance and
Related Costs
|
|
Lease Cancellation
and Other Costs
|
|
Asset Impairments
(1)
|
|
Total
|
||||||||
Balance at December 31, 2013
|
|
$
|
14
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
17
|
|
Restructuring provision
|
|
28
|
|
|
2
|
|
|
2
|
|
|
32
|
|
||||
Reversals of prior accruals
|
|
(10
|
)
|
|
(1
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Net current period charges - continuing operations
(2)
|
|
18
|
|
|
1
|
|
|
2
|
|
|
21
|
|
||||
Discontinued operations
(3)
|
|
2
|
|
|
—
|
|
|
—
|
|
|
2
|
|
||||
Total Net Current Period Charges
|
|
20
|
|
|
1
|
|
|
2
|
|
|
23
|
|
||||
Charges against reserve and currency
|
|
(26
|
)
|
|
(1
|
)
|
|
(2
|
)
|
|
(29
|
)
|
||||
Balance at December 31, 2014
|
|
8
|
|
|
3
|
|
|
—
|
|
|
11
|
|
||||
Restructuring provision
|
|
20
|
|
|
1
|
|
|
146
|
|
|
167
|
|
||||
Reversals of prior accruals
|
|
(6
|
)
|
|
(2
|
)
|
|
—
|
|
|
(8
|
)
|
||||
Net current period charges - continuing operations
(2)
|
|
14
|
|
|
(1
|
)
|
|
146
|
|
|
159
|
|
||||
Charges against reserve and currency
|
|
(18
|
)
|
|
(2
|
)
|
|
(146
|
)
|
|
(166
|
)
|
||||
Balance at December 31, 2015
|
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
||||
Restructuring provision
|
|
67
|
|
|
7
|
|
|
12
|
|
|
86
|
|
||||
Reversals of prior accruals
|
|
(13
|
)
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
||||
Net current period charges - continuing operations
(2)
|
|
54
|
|
|
7
|
|
|
12
|
|
|
73
|
|
||||
Charges against reserve and currency
|
|
(43
|
)
|
|
(2
|
)
|
|
(11
|
)
|
|
(56
|
)
|
||||
Balance at December 31, 2016
|
|
$
|
15
|
|
|
$
|
5
|
|
|
$
|
1
|
|
|
$
|
21
|
|
(1)
|
Charges associated with asset impairments represent the write-down of the related assets to their new cost basis and are recorded concurrently with the recognition of the provision.
|
(2)
|
Represents amount recognized within the Consolidated Statements of Income for the years shown.
|
(3)
|
Refer to Note 4 - Divestitures for additional information regarding Discontinued Operations.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Charges against reserve
|
|
$
|
(56
|
)
|
|
$
|
(166
|
)
|
|
$
|
(29
|
)
|
Asset impairments
|
|
11
|
|
|
146
|
|
|
2
|
|
|||
Effects of foreign currency and other non-cash items
|
|
(1
|
)
|
|
1
|
|
|
4
|
|
|||
Restructuring Cash Payments
|
|
$
|
(46
|
)
|
|
$
|
(19
|
)
|
|
$
|
(23
|
)
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Commercial Industries
|
|
$
|
41
|
|
|
$
|
8
|
|
|
$
|
11
|
|
Healthcare
|
|
19
|
|
|
3
|
|
|
4
|
|
|||
Public Sector
|
|
9
|
|
|
2
|
|
|
4
|
|
|||
Other
(1)
|
|
4
|
|
|
146
|
|
|
2
|
|
|||
Total Net Restructuring Charges
|
|
$
|
73
|
|
|
$
|
159
|
|
|
$
|
21
|
|
(1)
|
Refer to Note 6 - Land, Buildings, Equipment and Software, Net for additional information regarding the asset impairment in 2015.
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Other Current Assets
|
|
|
|
|
||||
Prepaid/deferred costs
|
|
$
|
87
|
|
|
$
|
92
|
|
Income taxes receivable
|
|
14
|
|
|
10
|
|
||
Value-added tax (VAT) receivable
|
|
18
|
|
|
16
|
|
||
Restricted cash
|
|
22
|
|
|
16
|
|
||
Inventories
(1)
|
|
41
|
|
|
41
|
|
||
Advances and deposits
|
|
29
|
|
|
28
|
|
||
Other
|
|
30
|
|
|
37
|
|
||
Total Other Current Assets
|
|
$
|
241
|
|
|
$
|
240
|
|
Other Current Liabilities
|
|
|
|
|
|
|
||
Income taxes payable
|
|
$
|
5
|
|
|
$
|
9
|
|
Other taxes payable
|
|
14
|
|
|
21
|
|
||
Consulting payable
|
|
12
|
|
|
11
|
|
||
Restructuring reserves
|
|
18
|
|
|
4
|
|
||
Legal settlements
|
|
78
|
|
|
57
|
|
||
Acquisition reserves
|
|
2
|
|
|
9
|
|
||
Due to customers
|
|
13
|
|
|
19
|
|
||
Software and hardware accruals
|
|
20
|
|
|
35
|
|
||
Servicer liabilities
|
|
—
|
|
|
10
|
|
||
Due to Atos
(2)
|
|
—
|
|
|
52
|
|
||
Health Enterprise settlement
|
|
48
|
|
|
216
|
|
||
NY MMIS wind down cost accrual
|
|
46
|
|
|
—
|
|
||
Other
|
|
355
|
|
|
402
|
|
||
Total Other Current Liabilities
|
|
$
|
611
|
|
|
$
|
845
|
|
Other Long-term Assets
|
|
|
|
|
|
|
||
Deferred taxes
|
|
$
|
14
|
|
|
$
|
13
|
|
Income taxes receivable
|
|
17
|
|
|
—
|
|
||
Prepaid pension costs
|
|
—
|
|
|
9
|
|
||
Internal use software, net
|
|
115
|
|
|
119
|
|
||
Product software, net
|
|
38
|
|
|
107
|
|
||
Customer contract costs, net
|
|
137
|
|
|
170
|
|
||
Deferred compensation plan investments
|
|
109
|
|
|
113
|
|
||
Unbilled contract receivables
|
|
14
|
|
|
53
|
|
||
Other
|
|
32
|
|
|
23
|
|
||
Total Other Long-term Assets
|
|
$
|
476
|
|
|
$
|
607
|
|
Other Long-term Liabilities
|
|
|
|
|
|
|
||
Income taxes payable
|
|
17
|
|
|
24
|
|
||
Unearned income
|
|
74
|
|
|
100
|
|
||
Other
|
|
82
|
|
|
77
|
|
||
Total Other Long-term Liabilities
|
|
$
|
173
|
|
|
$
|
201
|
|
(1)
|
Represents Finished goods inventory.
|
(2)
|
Refer to Note 4 - Divestitures for additional information.
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Escrow and cash collections related to receivable sales
|
|
$
|
—
|
|
|
$
|
10
|
|
Restricted cash - related party
1
|
|
18
|
|
|
—
|
|
||
Other restricted cash
|
|
4
|
|
|
6
|
|
||
Total Restricted Cash
|
|
$
|
22
|
|
|
$
|
16
|
|
(1)
|
Represents restricted cash associated with former parent guarantees of our contractual performance. Amounts will be held in escrow until the parent guarantees have been removed from the underlying customer, vendor or lease contracts.
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Related party notes payable
(1)
|
|
$
|
—
|
|
|
$
|
1,132
|
|
Current maturities of long-term debt
|
|
28
|
|
|
24
|
|
||
Total Short-term Debt
|
|
$
|
28
|
|
|
$
|
1,156
|
|
(1)
|
Refer to Note 20 - Related Party Transactions and Former Parent Company Investment for additional information.
|
|
|
|
|
December 31,
|
|||||||
|
|
Weighted Average Interest Rates at December 31, 2016
(1)
|
|
2016
|
|
2015
|
|||||
|
|
|
|
|
|
|
|
||||
Term loan A due 2021
|
|
2.99
|
%
|
|
$
|
694
|
|
|
$
|
—
|
|
Term loan B due 2023
|
|
6.81
|
%
|
|
750
|
|
|
—
|
|
||
Senior notes due 2024
|
|
10.51
|
%
|
|
510
|
|
|
—
|
|
||
Capital lease obligations
|
|
3.89
|
%
|
|
43
|
|
|
61
|
|
||
Principal Debt Balance
|
|
|
|
$
|
1,997
|
|
|
$
|
61
|
|
|
Debt issuance costs and unamortized discounts
|
|
|
|
(56
|
)
|
|
—
|
|
|||
Less: current maturities
|
|
|
|
(28
|
)
|
|
(24
|
)
|
|||
Total Long-term Debt
|
|
|
|
$
|
1,913
|
|
|
$
|
37
|
|
(1)
|
Represents weighted average effective interest rate which includes the effect of discounts and premiums on issued debt.
|
2017
(1)
|
|
|
2018
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
Thereafter
|
|
|
Total
|
|
|||||||
$
|
28
|
|
|
$
|
72
|
|
|
$
|
67
|
|
|
$
|
79
|
|
|
$
|
528
|
|
|
$
|
1,223
|
|
|
$
|
1,997
|
|
(1)
|
Quarterly long-term debt maturities for 2017 are
$7
,
$7
,
$7
and
$7
for the first, second, third and fourth quarters, respectively.
|
(i)
|
Senior Secured Term Loan A (Term Loan A) due 2021 with an aggregate principal amount of
$700
;
|
(ii)
|
Senior Secured Term Loan B (Term Loan B) due 2023 with an aggregate principal amount of
$750
;
|
(iii)
|
Senior Revolving Credit Facility (Revolving Credit Facility) due 2021 with an aggregate available amount of
$750
including a sublimit for up to
$300
available for the issuance of letters of credit.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Interest expense
|
|
$
|
14
|
|
|
$
|
8
|
|
|
$
|
11
|
|
Interest income
|
|
3
|
|
|
3
|
|
|
1
|
|
Currencies Hedged (Buy/Sell)
|
|
Gross
Notional
Value
|
|
Fair Value
Asset
(Liability)
(1)
|
||||
Philippine Peso/U.S. Dollar
|
|
$
|
52
|
|
|
$
|
(1
|
)
|
Indian Rupee/U.S. Dollar
|
|
33
|
|
|
—
|
|
||
Mexican Peso/U.S. Dollar
|
|
18
|
|
|
(1
|
)
|
||
Euro/U.S. Dollar
|
|
10
|
|
|
—
|
|
||
All Other
|
|
26
|
|
|
—
|
|
||
Total Foreign Exchange Hedging
|
|
$
|
139
|
|
|
$
|
(2
|
)
|
(1)
|
Represents the net receivable (payable) amount included in the Consolidated Balance Sheet at
December 31, 2016
.
|
|
|
|
|
December 31,
|
||||||
Designation of Derivatives
|
|
Balance Sheet Location
|
|
2016
|
|
2015
|
||||
Derivatives Designated as Hedging Instruments
|
|
|
|
|
||||||
Foreign exchange contracts – forwards
|
|
Other current liabilities
|
|
$
|
(3
|
)
|
|
$
|
(3
|
)
|
Derivatives NOT Designated as Hedging Instruments
|
|
|
|
|
||||||
Foreign exchange contracts – forwards
|
|
Other current assets
|
|
$
|
1
|
|
|
$
|
—
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||||
Derivatives in Cash Flow
Hedging Relationships
|
|
Derivative Gain (Loss) Recognized in OCI (Effective Portion)
|
|
Location of Derivative
Gain (Loss) Reclassified
from AOCI into Income
(Effective Portion)
|
|
Gain (Loss) Reclassified from AOCI to Income (Effective Portion)
|
||||||||||||||||||||
|
2016
|
|
2015
|
|
2014
|
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||||
Foreign exchange contracts – forwards
|
|
$
|
(2
|
)
|
|
$
|
(4
|
)
|
|
$
|
—
|
|
|
Cost of outsourcing
|
|
$
|
(2
|
)
|
|
$
|
(5
|
)
|
|
$
|
3
|
|
|
|
|
|
Year Ended December 31,
|
||||||||||
Derivatives NOT Designated as Hedging Instruments
|
|
Location of Derivative Loss
|
|
2016
|
|
2015
|
|
2014
|
||||||
Foreign exchange contracts – forwards
|
|
Other expense – Currency losses, net
|
|
$
|
1
|
|
|
$
|
3
|
|
|
$
|
2
|
|
|
|
As of December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Assets:
|
|
|
|
|
||||
Foreign exchange contracts - forwards
|
|
$
|
1
|
|
|
$
|
—
|
|
Deferred compensation investments in cash surrender life insurance
|
|
99
|
|
|
92
|
|
||
Deferred compensation investments in mutual funds
|
|
10
|
|
|
21
|
|
||
Total
|
|
$
|
110
|
|
|
$
|
113
|
|
Liabilities:
|
|
|
|
|
||||
Foreign exchange contracts - forwards
|
|
$
|
3
|
|
|
$
|
3
|
|
Deferred compensation plan liabilities
|
|
113
|
|
|
110
|
|
||
Total
|
|
$
|
116
|
|
|
$
|
113
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||||
|
Carrying
Amount
|
|
Fair
Value
|
|
Carrying
Amount
|
|
Fair
Value
|
||||||||
Cash and cash equivalents
|
$
|
390
|
|
|
$
|
390
|
|
|
$
|
140
|
|
|
$
|
140
|
|
Restricted cash - related party
|
18
|
|
|
18
|
|
|
—
|
|
|
—
|
|
||||
Accounts receivable, net
|
1,286
|
|
|
1,286
|
|
|
1,246
|
|
|
1,246
|
|
||||
Short-term debt
|
28
|
|
|
28
|
|
|
24
|
|
|
24
|
|
||||
Long-term debt
|
1,913
|
|
|
1,933
|
|
|
37
|
|
|
37
|
|
|
|
Pension Benefits
|
||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Change in Benefit Obligation:
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation, January 1
|
|
$
|
74
|
|
|
$
|
74
|
|
|
$
|
157
|
|
|
$
|
177
|
|
Service cost
|
|
—
|
|
|
—
|
|
|
2
|
|
|
3
|
|
||||
Interest cost
|
|
3
|
|
|
3
|
|
|
5
|
|
|
6
|
|
||||
Actuarial (gain) loss
|
|
13
|
|
|
(2
|
)
|
|
27
|
|
|
(13
|
)
|
||||
Currency exchange rate changes
|
|
—
|
|
|
—
|
|
|
(19
|
)
|
|
(14
|
)
|
||||
Benefits paid/settlements
|
|
(1
|
)
|
|
(1
|
)
|
|
(8
|
)
|
|
(5
|
)
|
||||
Other
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
||||
Benefit Obligation, December 31
|
|
$
|
89
|
|
|
$
|
74
|
|
|
$
|
164
|
|
|
$
|
157
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in Plan Assets:
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, January 1
|
|
$
|
47
|
|
|
$
|
45
|
|
|
$
|
150
|
|
|
$
|
158
|
|
Actual return on plan assets
|
|
2
|
|
|
(2
|
)
|
|
15
|
|
|
3
|
|
||||
Employer contribution
|
|
4
|
|
|
4
|
|
|
2
|
|
|
4
|
|
||||
Currency exchange rate changes
|
|
—
|
|
|
—
|
|
|
(19
|
)
|
|
(12
|
)
|
||||
Benefits paid/settlements
|
|
(1
|
)
|
|
(1
|
)
|
|
(8
|
)
|
|
(5
|
)
|
||||
Other
|
|
—
|
|
|
1
|
|
|
—
|
|
|
2
|
|
||||
Fair Value of Plan Assets, December 31
|
|
$
|
52
|
|
|
$
|
47
|
|
|
$
|
140
|
|
|
$
|
150
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net Funded Status at December 31
(1)
|
|
$
|
(37
|
)
|
|
$
|
(27
|
)
|
|
$
|
(24
|
)
|
|
$
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
Amounts Recognized in the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
||||||
Other long-term assets
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
9
|
|
Accrued compensation and benefit costs
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
(1
|
)
|
||||
Pension and other benefit liabilities
|
|
(37
|
)
|
|
(27
|
)
|
|
(22
|
)
|
|
(15
|
)
|
||||
Net Amounts Recognized
|
|
$
|
(37
|
)
|
|
$
|
(27
|
)
|
|
$
|
(24
|
)
|
|
$
|
(7
|
)
|
(1)
|
Includes under-funded and un-funded plans.
|
|
|
Pension Benefits
|
||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net actuarial loss
|
|
$
|
31
|
|
|
$
|
18
|
|
|
$
|
42
|
|
|
$
|
29
|
|
Accumulated Benefit Obligation
|
|
$
|
89
|
|
|
$
|
74
|
|
|
$
|
157
|
|
|
$
|
154
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
|
|
Projected benefit obligation
|
|
Accumulated benefit obligation
|
|
Fair value of plan assets
|
|
Projected benefit obligation
|
|
Accumulated benefit obligation
|
|
Fair value of plan assets
|
||||||||||||
Underfunded Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S.
|
|
$
|
89
|
|
|
$
|
89
|
|
|
$
|
52
|
|
|
$
|
74
|
|
|
$
|
74
|
|
|
$
|
46
|
|
Non U.S.
|
|
162
|
|
|
156
|
|
|
140
|
|
|
50
|
|
|
48
|
|
|
36
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unfunded Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Non U.S.
|
|
2
|
|
|
1
|
|
|
—
|
|
|
2
|
|
|
1
|
|
|
—
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total Underfunded and Unfunded Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S.
|
|
$
|
89
|
|
|
$
|
89
|
|
|
$
|
52
|
|
|
$
|
74
|
|
|
$
|
74
|
|
|
$
|
46
|
|
Non U.S.
|
|
164
|
|
|
157
|
|
|
140
|
|
|
52
|
|
|
49
|
|
|
36
|
|
||||||
Total
|
|
$
|
253
|
|
|
$
|
246
|
|
|
$
|
192
|
|
|
$
|
126
|
|
|
$
|
123
|
|
|
$
|
82
|
|
|
|
Fair Value of Pension Plan Assets
|
|
Pension Benefit Obligations
|
|
Net Funded Status
|
||||||
U.S.
|
|
$
|
52
|
|
|
$
|
89
|
|
|
$
|
(37
|
)
|
U.K.
|
|
98
|
|
|
107
|
|
|
(9
|
)
|
|||
Canada
|
|
39
|
|
|
49
|
|
|
(10
|
)
|
|||
Other
|
|
3
|
|
|
8
|
|
|
(5
|
)
|
|||
Total
|
|
$
|
192
|
|
|
$
|
253
|
|
|
$
|
(61
|
)
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||
Components of Net Periodic Benefit Costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Service cost
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
2
|
|
|
$
|
3
|
|
|
$
|
6
|
|
Interest cost
|
|
3
|
|
|
3
|
|
|
3
|
|
|
5
|
|
|
6
|
|
|
7
|
|
||||||
Expected return on plan assets
|
|
(4
|
)
|
|
(4
|
)
|
|
(3
|
)
|
|
(8
|
)
|
|
(9
|
)
|
|
(10
|
)
|
||||||
Recognized net actuarial loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
2
|
|
|
—
|
|
||||||
Defined Benefit Plans
|
|
(1
|
)
|
|
(1
|
)
|
|
5
|
|
|
—
|
|
|
2
|
|
|
3
|
|
||||||
Defined contribution plans
|
|
28
|
|
|
28
|
|
|
27
|
|
|
7
|
|
|
6
|
|
|
4
|
|
||||||
Net Periodic Benefit Cost
|
|
27
|
|
|
27
|
|
|
32
|
|
|
7
|
|
|
8
|
|
|
7
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other changes in plan assets and benefit obligations recognized in Other Comprehensive Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net actuarial (gain) loss
|
|
13
|
|
|
4
|
|
|
9
|
|
|
18
|
|
|
(9
|
)
|
|
34
|
|
||||||
Amortization of net actuarial loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
(2
|
)
|
|
—
|
|
||||||
Total Recognized in Other Comprehensive Income
|
|
13
|
|
|
4
|
|
|
9
|
|
|
17
|
|
|
(11
|
)
|
|
34
|
|
||||||
Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Income
|
|
$
|
40
|
|
|
$
|
31
|
|
|
$
|
41
|
|
|
$
|
24
|
|
|
$
|
(3
|
)
|
|
$
|
41
|
|
|
|
December 31, 2016
|
||||||||||||||||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||||||||||||||||||||||||||||
Asset Class
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
%
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
%
|
||||||||||||||||||
Cash and cash equivalents
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
6
|
%
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
%
|
Equity Securities
|
|
9
|
|
|
24
|
|
|
—
|
|
|
33
|
|
|
63
|
%
|
|
—
|
|
|
61
|
|
|
—
|
|
|
61
|
|
|
44
|
%
|
||||||||
Fixed Income Securities
|
|
10
|
|
|
6
|
|
|
—
|
|
|
16
|
|
|
31
|
%
|
|
—
|
|
|
60
|
|
|
—
|
|
|
60
|
|
|
43
|
%
|
||||||||
Other
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
11
|
|
|
8
|
|
|
19
|
|
|
13
|
%
|
||||||||
Total Fair Value of Plan Assets
|
|
$
|
22
|
|
|
$
|
30
|
|
|
$
|
—
|
|
|
$
|
52
|
|
|
100
|
%
|
|
$
|
—
|
|
|
$
|
132
|
|
|
$
|
8
|
|
|
$
|
140
|
|
|
100
|
%
|
|
|
December 31, 2015
|
||||||||||||||||||||||||||||||||||||
|
|
U.S. Plans
|
|
|
|
Non-U.S. Plans
|
|
|
||||||||||||||||||||||||||||||
Asset Class
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
%
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
%
|
||||||||||||||||||
Cash and cash equivalents
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
6
|
%
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
1
|
%
|
Equity Securities
|
|
17
|
|
|
8
|
|
|
—
|
|
|
25
|
|
|
53
|
%
|
|
—
|
|
|
61
|
|
|
—
|
|
|
61
|
|
|
40
|
%
|
||||||||
Fixed Income Securities
|
|
—
|
|
|
19
|
|
|
—
|
|
|
19
|
|
|
41
|
%
|
|
—
|
|
|
73
|
|
|
—
|
|
|
73
|
|
|
49
|
%
|
||||||||
Other
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
4
|
|
|
11
|
|
|
15
|
|
|
10
|
%
|
||||||||
Total Fair Value of Plan Assets
|
|
$
|
20
|
|
|
$
|
27
|
|
|
$
|
—
|
|
|
$
|
47
|
|
|
100
|
%
|
|
$
|
1
|
|
|
$
|
138
|
|
|
$
|
11
|
|
|
$
|
150
|
|
|
100
|
%
|
|
|
2016
|
|
2015
|
||||
|
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
Equity investments
|
|
55%
|
|
41%
|
|
55%
|
|
55%
|
Fixed income investments
|
|
25%
|
|
45%
|
|
25%
|
|
36%
|
Real estate
|
|
—%
|
|
4%
|
|
—%
|
|
4%
|
Other
|
|
20%
|
|
10%
|
|
20%
|
|
5%
|
Total Investment Strategy
|
|
100%
|
|
100%
|
|
100%
|
|
100%
|
|
|
Pension Benefits
|
||||||||||
|
|
U.S.
|
|
Non-U.S.
|
|
Total
|
||||||
2017
|
|
$
|
1
|
|
|
$
|
4
|
|
|
$
|
5
|
|
2018
|
|
2
|
|
|
4
|
|
|
6
|
|
|||
2019
|
|
2
|
|
|
4
|
|
|
6
|
|
|||
2020
|
|
2
|
|
|
4
|
|
|
6
|
|
|||
2021
|
|
2
|
|
|
5
|
|
|
7
|
|
|||
Years 2022-2025
|
|
16
|
|
|
27
|
|
|
43
|
|
|
|
Pension Benefits
|
||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||
|
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
||||||
Discount rate
|
|
4.2
|
%
|
|
3.2
|
%
|
|
4.3
|
%
|
|
3.9
|
%
|
|
4.0
|
%
|
|
3.4
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
1.0
|
%
|
|
—
|
%
|
|
1.0
|
%
|
|
—
|
%
|
|
1.1
|
%
|
|
|
Pension Benefits
|
||||||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||||||
|
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
|
U.S.
|
|
Non-U.S.
|
||||||||
Discount rate
|
|
4.2
|
%
|
|
3.9
|
%
|
|
4.3
|
%
|
|
3.9
|
%
|
|
4.0
|
%
|
|
3.4
|
%
|
|
4.9
|
%
|
|
4.4
|
%
|
Expected return on plan assets
|
|
7.8
|
%
|
|
5.7
|
%
|
|
7.8
|
%
|
|
5.7
|
%
|
|
7.8
|
%
|
|
5.8
|
%
|
|
7.8
|
%
|
|
6.6
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
1.0
|
%
|
|
—
|
%
|
|
1.0
|
%
|
|
—
|
%
|
|
1.1
|
%
|
|
3.0
|
%
|
|
3.5
|
%
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Domestic (loss) income
|
|
$
|
(1,329
|
)
|
|
$
|
(654
|
)
|
|
$
|
(45
|
)
|
Foreign (loss) income
|
|
102
|
|
|
80
|
|
|
55
|
|
|||
(Loss) Income Before Income Taxes
|
|
$
|
(1,227
|
)
|
|
$
|
(574
|
)
|
|
$
|
10
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Federal Income Taxes
|
|
|
|
|
|
|
||||||
Current
|
|
$
|
(116
|
)
|
|
$
|
(130
|
)
|
|
$
|
59
|
|
Deferred
|
|
(132
|
)
|
|
(99
|
)
|
|
(108
|
)
|
|||
Foreign Income Taxes
|
|
|
|
|
|
|
||||||
Current
|
|
31
|
|
|
24
|
|
|
26
|
|
|||
Deferred
|
|
(3
|
)
|
|
6
|
|
|
1
|
|
|||
State Income Taxes
|
|
|
|
|
|
|
||||||
Current
|
|
1
|
|
|
(17
|
)
|
|
14
|
|
|||
Deferred
|
|
(25
|
)
|
|
(22
|
)
|
|
(16
|
)
|
|||
Total Benefit
|
|
$
|
(244
|
)
|
|
$
|
(238
|
)
|
|
$
|
(24
|
)
|
|
|
Year Ended December 31,
|
|||||||
|
|
2016
|
|
2015
|
|
2014
|
|||
U.S. federal statutory income tax rate
|
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
Nondeductible expenses
(1)
|
|
(19.0
|
)%
|
|
(1.3
|
)%
|
|
81.0
|
%
|
Effect of tax law changes
|
|
—
|
%
|
|
0.9
|
%
|
|
(51.6
|
)%
|
Change in valuation allowance for deferred tax assets
|
|
0.1
|
%
|
|
(1.0
|
)%
|
|
35.3
|
%
|
State taxes, net of federal benefit
|
|
1.8
|
%
|
|
4.2
|
%
|
|
42.0
|
%
|
Audit and other tax return adjustments
|
|
1.4
|
%
|
|
0.1
|
%
|
|
(87.5
|
)%
|
Tax-exempt income, credits and incentives
|
|
0.7
|
%
|
|
0.7
|
%
|
|
(63.9
|
)%
|
Foreign rate differential adjusted for U.S. taxation of foreign profits
(2)
|
|
0.7
|
%
|
|
2.4
|
%
|
|
(228.8
|
)%
|
Other
|
|
(0.8
|
)%
|
|
0.5
|
%
|
|
(1.5
|
)%
|
Effective Income Tax Rate
|
|
19.9
|
%
|
|
41.5
|
%
|
|
(240.0
|
)%
|
(1)
|
In 2016, Nondeductible expenses primarily related to the nondeductible portion of the book goodwill impairment charge.
|
(2)
|
The “U.S. taxation of foreign profits” represents the U.S. tax, net of foreign tax credits, associated with actual and deemed repatriations of earnings from our non-U.S. subsidiaries.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Pre-tax income
|
|
$
|
(244
|
)
|
|
$
|
(238
|
)
|
|
$
|
(24
|
)
|
Discontinued operations
(1)
|
|
—
|
|
|
81
|
|
|
7
|
|
|||
Common shareholders' equity:
|
|
|
|
|
|
|
|
|
||||
Changes in defined benefit plans
|
|
8
|
|
|
2
|
|
|
(11
|
)
|
|||
Stock option and incentive plans, net
|
|
—
|
|
|
(6
|
)
|
|
(10
|
)
|
|||
Cash flow hedges
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|||
Total Income Tax Benefit
|
|
$
|
(236
|
)
|
|
$
|
(161
|
)
|
|
$
|
(39
|
)
|
(1)
|
Refer to Note 4 - Divestitures for additional information regarding discontinued operations.
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
Balance at January 1
|
|
$
|
24
|
|
|
$
|
32
|
|
|
$
|
41
|
|
Additions related to current year
|
|
1
|
|
|
3
|
|
|
5
|
|
|||
Additions related to prior years positions
|
|
—
|
|
|
—
|
|
|
1
|
|
|||
Reductions related to prior years positions
|
|
(5
|
)
|
|
(10
|
)
|
|
(13
|
)
|
|||
Settlements with taxing authorities
(1)
|
|
(5
|
)
|
|
—
|
|
|
(2
|
)
|
|||
Currency
|
|
(1
|
)
|
|
(1
|
)
|
|
—
|
|
|||
Balance at December 31
|
|
$
|
14
|
|
|
$
|
24
|
|
|
$
|
32
|
|
(1)
|
2016 settlement results in
$(5)
cash paid; 2014 settlement of
$(2)
results in
no
cash paid.
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Deferred Tax Assets
|
|
|
|
|
||||
Net operating losses
|
|
$
|
42
|
|
|
$
|
71
|
|
Operating reserves, accruals and deferrals
|
|
155
|
|
|
184
|
|
||
Deferred compensation
|
|
101
|
|
|
83
|
|
||
Pension
|
|
18
|
|
|
11
|
|
||
Other
|
|
44
|
|
|
65
|
|
||
Subtotal
|
|
360
|
|
|
414
|
|
||
Valuation allowance
|
|
(24
|
)
|
|
(38
|
)
|
||
Total
|
|
$
|
336
|
|
|
$
|
376
|
|
|
|
|
|
|
||||
Deferred Tax Liabilities
|
|
|
|
|
||||
Unearned income
|
|
$
|
217
|
|
|
$
|
230
|
|
Intangibles and goodwill
|
|
680
|
|
|
808
|
|
||
Depreciation
|
|
15
|
|
|
61
|
|
||
Other
|
|
29
|
|
|
28
|
|
||
Total
|
|
$
|
941
|
|
|
$
|
1,127
|
|
|
|
|
|
|
||||
Total Deferred Taxes, Net
|
|
$
|
(605
|
)
|
|
$
|
(751
|
)
|
•
|
Guarantees on behalf of our subsidiaries with respect to real estate leases. These lease guarantees may remain in effect subsequent to the sale of the subsidiary.
|
•
|
Agreements to indemnify various service providers, trustees and bank agents from any third-party claims related to their performance on our behalf, with the exception of claims that result from the third-party's own willful misconduct or gross negligence.
|
•
|
Guarantees of our performance in certain services contracts to our customers and indirectly the performance of third parties with whom we have subcontracted for their services. This includes indemnifications to customers for losses that may be sustained as a result of our performance of services at a customer's location.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Stock-based compensation expense, pre-tax
|
|
$
|
23
|
|
|
$
|
19
|
|
|
$
|
28
|
|
Income tax benefit recognized in earnings
|
|
9
|
|
|
7
|
|
|
11
|
|
|
|
2016
|
|
2015
|
|
2014
|
|||||||||||||||
(shares in thousands)
|
|
Shares
|
|
Weighted
Average Grant
Date Fair
Value
|
|
Shares
|
|
Weighted
Average Grant
Date Fair
Value
|
|
Shares
|
|
Weighted
Average Grant
Date Fair
Value
|
|||||||||
Restricted Stock Units
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Outstanding at January 1
|
|
782
|
|
|
$
|
11.70
|
|
|
3,422
|
|
|
$
|
8.47
|
|
|
4,842
|
|
|
$
|
8.78
|
|
Granted
|
|
2,602
|
|
|
9.61
|
|
|
260
|
|
|
11.86
|
|
|
433
|
|
|
12.08
|
|
|||
Vested
|
|
(119
|
)
|
|
9.43
|
|
|
(2,768
|
)
|
|
7.83
|
|
|
(1,499
|
)
|
|
10.54
|
|
|||
Canceled
|
|
(121
|
)
|
|
10.55
|
|
|
(132
|
)
|
|
9.52
|
|
|
(354
|
)
|
|
8.39
|
|
|||
Impact of Spin-off
(1)
|
|
(1,183
|
)
|
|
n/a
|
|
|
—
|
|
|
n/a
|
|
|
—
|
|
|
n/a
|
|
|||
Outstanding at December 31
|
|
1,961
|
|
|
13.99
|
|
|
782
|
|
|
11.70
|
|
|
3,422
|
|
|
8.47
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Performance Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Outstanding at January 1
|
|
7,522
|
|
|
$
|
11.57
|
|
|
5,771
|
|
|
$
|
11.68
|
|
|
1,421
|
|
|
$
|
9.02
|
|
Granted
|
|
1,850
|
|
|
9.35
|
|
|
3,583
|
|
|
10.68
|
|
|
5,674
|
|
|
12.28
|
|
|||
Vested
|
|
—
|
|
|
—
|
|
|
(610
|
)
|
|
7.88
|
|
|
(366
|
)
|
|
10.71
|
|
|||
Canceled
|
|
(1,478
|
)
|
|
11.96
|
|
|
(1,222
|
)
|
|
11.36
|
|
|
(958
|
)
|
|
11.63
|
|
|||
Impact of Spin-off
(1)
|
|
(2,968
|
)
|
|
n/a
|
|
|
—
|
|
|
n/a
|
|
|
—
|
|
|
n/a
|
|
|||
Outstanding at December 31
|
|
4,926
|
|
|
13.99
|
|
|
7,522
|
|
|
11.57
|
|
|
5,771
|
|
|
11.68
|
|
(1)
|
Stock-based compensation was converted from former parent stock into Conduent common stock at Spin-off.
|
Awards
|
|
Unrecognized Compensation
|
|
Remaining Weighted-Average Vesting Period (Years)
|
||
Restricted Stock Units
|
|
$
|
19
|
|
|
2.3
|
Performance Shares
|
|
22
|
|
|
1.9
|
|
Total
|
|
$
|
41
|
|
|
|
Awards
|
|
December 31, 2016
|
||
Restricted Stock Units
|
|
$
|
27
|
|
Performance Shares
|
|
69
|
|
|
|
Options
|
||||||
|
|
Outstanding
|
|
Exercisable
|
||||
Aggregate intrinsic value
|
|
$
|
3
|
|
|
$
|
3
|
|
Weighted-average remaining contractual life (years)
|
|
2.0
|
|
|
2.0
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||||||||||||
Awards
|
|
Total Intrinsic Value
|
|
Cash Received
|
|
Tax Benefit
|
|
Total Intrinsic Value
|
|
Cash Received
|
|
Tax Benefit
|
|
Total Intrinsic Value
|
|
Cash Received
|
|
Tax Benefit
|
||||||||||||||||||
Restricted Stock Units
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
30
|
|
|
$
|
—
|
|
|
$
|
11
|
|
|
$
|
19
|
|
|
$
|
—
|
|
|
$
|
7
|
|
Performance Shares
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
2
|
|
|
5
|
|
|
—
|
|
|
2
|
|
|||||||||
Stock Options
|
|
3
|
|
|
9
|
|
|
1
|
|
|
14
|
|
|
19
|
|
|
5
|
|
|
42
|
|
|
55
|
|
|
15
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||||||||
|
|
Pre-tax
|
|
Net of Tax
|
|
Pre-tax
|
|
Net of Tax
|
|
Pre-tax
|
|
Net of Tax
|
||||||||||||
Translation Adjustments Losses
|
|
$
|
(135
|
)
|
|
$
|
(135
|
)
|
|
$
|
(60
|
)
|
|
$
|
(60
|
)
|
|
$
|
(44
|
)
|
|
$
|
(44
|
)
|
Unrealized Gains (Losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Changes in fair value of cash flow hedges gains (losses)
|
|
(2
|
)
|
|
(1
|
)
|
|
(4
|
)
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
||||||
Changes in cash flow hedges reclassed to earnings
(1)
|
|
2
|
|
|
1
|
|
|
5
|
|
|
3
|
|
|
(3
|
)
|
|
(2
|
)
|
||||||
Net Unrealized Gains (Losses)
|
|
—
|
|
|
—
|
|
|
1
|
|
|
1
|
|
|
(3
|
)
|
|
(2
|
)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Defined Benefit Plans (Losses) Gains
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net actuarial/prior service (losses) gains
|
|
(31
|
)
|
|
(23
|
)
|
|
5
|
|
|
4
|
|
|
(43
|
)
|
|
(32
|
)
|
||||||
Actuarial loss amortization/settlement
(2)
|
|
1
|
|
|
1
|
|
|
2
|
|
|
2
|
|
|
—
|
|
|
—
|
|
||||||
Other gains (losses)
(3)
|
|
3
|
|
|
2
|
|
|
2
|
|
|
1
|
|
|
7
|
|
|
7
|
|
||||||
Changes in Defined Benefit Plans (Losses) Gains
|
|
(27
|
)
|
|
(20
|
)
|
|
9
|
|
|
7
|
|
|
(36
|
)
|
|
(25
|
)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other Comprehensive Loss
|
|
$
|
(162
|
)
|
|
$
|
(155
|
)
|
|
$
|
(50
|
)
|
|
$
|
(52
|
)
|
|
$
|
(83
|
)
|
|
$
|
(71
|
)
|
(1)
|
Reclassified to Cost of sales - refer to Note 11 - Financial Instruments for additional information regarding our cash flow hedges.
|
(2)
|
Reclassified to Total Net Periodic Benefit Cost - refer to Note 13 - Employee Benefit Plans for additional information.
|
(3)
|
Primarily represents currency impact on cumulative amount of benefit plan net actuarial losses and prior service credits in AOCL.
|
|
|
December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Cumulative translation adjustments
(1)
|
|
$
|
(472
|
)
|
|
$
|
(147
|
)
|
|
$
|
(87
|
)
|
Other unrealized losses, net
|
|
(1
|
)
|
|
(1
|
)
|
|
(2
|
)
|
|||
Benefit plans net actuarial losses and prior service credits
|
|
(53
|
)
|
|
(33
|
)
|
|
(40
|
)
|
|||
Total Accumulated Other Comprehensive Loss
|
|
$
|
(526
|
)
|
|
$
|
(181
|
)
|
|
$
|
(129
|
)
|
(1)
|
2016 includes
$190
of AOCL transfered from former parent as part of the Spin-off.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Research and development
|
|
$
|
25
|
|
|
$
|
43
|
|
|
$
|
40
|
|
Selling, administrative and general
|
|
140
|
|
|
127
|
|
|
135
|
|
|||
Total Allocated Corporate Expenses
|
|
$
|
165
|
|
|
$
|
170
|
|
|
$
|
175
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Cash pooling and general financing activities
|
|
$
|
(466
|
)
|
|
$
|
(396
|
)
|
|
$
|
(525
|
)
|
Corporate cost allocations
|
|
165
|
|
|
170
|
|
|
175
|
|
|||
Income taxes
|
|
(157
|
)
|
|
168
|
|
|
44
|
|
|||
Divestitures and acquisitions, net
|
|
54
|
|
|
(742
|
)
|
|
290
|
|
|||
Capitalization of related party notes payable
|
|
—
|
|
|
1,017
|
|
|
—
|
|
|||
Total net transfers (to) from former parent
|
|
(404
|
)
|
|
217
|
|
|
(16
|
)
|
|||
Stock-based compensation
|
|
(23
|
)
|
|
(19
|
)
|
|
(28
|
)
|
|||
Capitalization of related party notes payable
|
|
—
|
|
|
(1,017
|
)
|
|
—
|
|
|||
Other, net
|
|
(161
|
)
|
|
147
|
|
|
8
|
|
|||
Total Net transfers to former parent per Consolidated Statements of Cash Flows
|
|
$
|
(588
|
)
|
|
$
|
(672
|
)
|
|
$
|
(36
|
)
|
(in millions, except per-share data)
|
|
First
Quarter
(1)
|
|
Second
Quarter
(1)
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Full
Year
|
||||||||||
2016
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenues
|
|
$
|
1,685
|
|
|
$
|
1,613
|
|
|
$
|
1,596
|
|
|
$
|
1,514
|
|
|
$
|
6,408
|
|
Costs and Expenses
|
|
1,739
|
|
|
1,647
|
|
|
1,594
|
|
|
2,655
|
|
|
7,635
|
|
|||||
(Loss) Income before Income Taxes
|
|
(54
|
)
|
|
(34
|
)
|
|
2
|
|
|
(1,141
|
)
|
|
(1,227
|
)
|
|||||
Income tax (benefit) expense
|
|
(31
|
)
|
|
(24
|
)
|
|
1
|
|
|
(190
|
)
|
|
(244
|
)
|
|||||
Net (Loss) Income
|
|
$
|
(23
|
)
|
|
$
|
(10
|
)
|
|
$
|
1
|
|
|
$
|
(951
|
)
|
|
$
|
(983
|
)
|
Basic (Loss) Earnings per Share
(2)
:
|
|
$
|
(0.12
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
0.01
|
|
|
$
|
(4.69
|
)
|
|
$
|
(4.85
|
)
|
Diluted (Loss) Earnings per Share
(2)
:
|
|
$
|
(0.12
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
0.01
|
|
|
$
|
(4.69
|
)
|
|
$
|
(4.85
|
)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2015
|
|
|
||||||||||||||||||
Revenues
|
|
$
|
1,678
|
|
|
$
|
1,683
|
|
|
$
|
1,571
|
|
|
$
|
1,730
|
|
|
$
|
6,662
|
|
Costs and Expenses
|
|
1,698
|
|
|
1,855
|
|
|
1,961
|
|
|
1,722
|
|
|
7,236
|
|
|||||
(Loss) Income before Income Taxes
|
|
(20
|
)
|
|
(172
|
)
|
|
(390
|
)
|
|
8
|
|
|
(574
|
)
|
|||||
Income tax expense
|
|
(14
|
)
|
|
(69
|
)
|
|
(154
|
)
|
|
(1
|
)
|
|
(238
|
)
|
|||||
(Loss) Income from Continuing Operations
|
|
(6
|
)
|
|
(103
|
)
|
|
(236
|
)
|
|
9
|
|
|
(336
|
)
|
|||||
Income (loss) from discontinued operations, net of tax
|
|
34
|
|
|
(95
|
)
|
|
(3
|
)
|
|
(14
|
)
|
|
(78
|
)
|
|||||
Net Income (Loss)
|
|
$
|
28
|
|
|
$
|
(198
|
)
|
|
$
|
(239
|
)
|
|
$
|
(5
|
)
|
|
$
|
(414
|
)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic Earnings (Loss) per Share
(2)
:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Continuing operations
|
|
$
|
(0.03
|
)
|
|
$
|
(0.50
|
)
|
|
$
|
(1.17
|
)
|
|
$
|
0.05
|
|
|
$
|
(1.65
|
)
|
Discontinued operations
|
|
0.17
|
|
|
(0.47
|
)
|
|
(0.01
|
)
|
|
(0.08
|
)
|
|
(0.39
|
)
|
|||||
Total Basic Earnings(Loss) per Share:
|
|
$
|
0.14
|
|
|
$
|
(0.97
|
)
|
|
$
|
(1.18
|
)
|
|
$
|
(0.03
|
)
|
|
$
|
(2.04
|
)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Diluted Earnings (Loss) per Share
(2)
:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Continuing operations
|
|
$
|
(0.03
|
)
|
|
$
|
(0.50
|
)
|
|
$
|
(1.17
|
)
|
|
$
|
0.05
|
|
|
$
|
(1.65
|
)
|
Discontinued operations
|
|
0.17
|
|
|
(0.47
|
)
|
|
(0.01
|
)
|
|
(0.08
|
)
|
|
(0.39
|
)
|
|||||
Total Diluted Earnings (Loss) per Share
|
|
$
|
0.14
|
|
|
$
|
(0.97
|
)
|
|
$
|
(1.18
|
)
|
|
$
|
(0.03
|
)
|
|
$
|
(2.04
|
)
|
(1)
|
During the second quarter 2016 closing process, we determined that the first quarter 2016 income tax benefit of $25 million should have been $6 million higher. This additional income tax benefit was adjusted for and included in the six month results ended June 30, 2016. The Company concluded that this correction was not material to the Condensed Combined Financial Statements for the three months ended March 31, 2016.
|
(2)
|
The sum of quarterly earnings per share may differ from the full-year amounts due to rounding, or in the case of diluted earnings per share, because securities that are anti-dilutive in certain quarters may not be anti-dilutive on a full-year basis.
|
Name
|
|
Age
|
|
Present Position
|
|
Year Appointed to Present Position
|
|
Conduent Officer Since
|
David Amoriell
|
|
60
|
|
Executive Vice President & President, Public Sector
|
|
2017
|
|
2017
|
Jay Chu
|
|
58
|
|
Vice President & Chief Accounting Officer
|
|
2017
|
|
2017
|
Jeffrey Friedel
|
|
52
|
|
Executive Vice President & Chief People Officer
|
|
2017
|
|
2017
|
James Michael Peffer
|
|
55
|
|
Executive Vice President, General Counsel & Secretary
|
|
2017
|
|
2017
|
Ashok Vemuri*
|
|
48
|
|
Chief Executive Officer
|
|
2017
|
|
2017
|
Brian J. Webb-Walsh
|
|
41
|
|
Executive Vice President & Chief Financial Officer
|
|
2017
|
|
2017
|
*
|
Member of Conduent Board of Directors
|
(a)
|
(1) Index to Financial Statements and Financial Statement Schedule, incorporated by reference or filed as part of this report:
|
▪
|
Report of Independent Registered Public Accounting Firm including Report on Financial Statement Schedule;
|
▪
|
Consolidated Statements of Income (Loss) for each of the years in the three-year period ended December 31, 2016;
|
▪
|
Consolidated Statements of Comprehensive Loss for each of the years in the three-year period ended December 31, 2016;
|
▪
|
Consolidated Balance Sheets as of December 31, 2016 and 2015;
|
▪
|
Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2016;
|
▪
|
Consolidated Statements of Shareholders' Equity for each of the years in the three-year period ended December 31, 2016;
|
▪
|
Notes to the Consolidated Financial Statements;
|
▪
|
Schedule II - Valuation and Qualifying Accounts for the three years ended December 31, 2016; and
|
▪
|
All other schedules are omitted as they are not applicable, or the information required is included in the financial statements or notes thereto.
|
(3)
|
The exhibits filed herewith or incorporated herein by reference are set forth in the Index of Exhibits included herein.
|
(b)
|
The management contracts or compensatory plans or arrangements listed in the “Index of Exhibits” that are applicable to the executive officers named in the Summary Compensation Table which appears in Registrant's 2017 Proxy Statement or to our directors are preceded by an asterisk (*).
|
CONDUENT INCORPORATED
|
|
|
|
/s/ A
SHOK
V
EMURI
|
|
Ashok Vemuri
Chief Executive Officer
March 10, 2017
|
|
Signature
|
|
Title
|
Principal Executive Officer:
|
|
|
/
S
/ A
SHOK
V
EMURI
|
|
Chief Executive Officer and Director
|
Ashok Vemuri
|
|
|
Principal Financial Officer:
|
|
|
/
S
/ B
RIAN
W
EBB
-W
ALSH
|
|
Executive Vice President and Chief Financial Officer
|
Brian Webb-Walsh
|
|
|
Principal Accounting Officer:
|
|
|
/
S
/ J
AY
T. C
HU
|
|
Vice President and Chief Accounting Officer
|
Jay T. Chu
|
|
|
/
S
/ P
AUL
S. G
ALANT
|
|
Director
|
Paul S. Galant
|
|
|
/
S
/ J
OIE
A. G
REGOR
|
|
Director
|
Joie A. Gregor
|
|
|
/s/ V
INCENT
J. I
NTRIERI
|
|
Director
|
Vincent J. Intrieri
|
|
|
/
S
/ C
OURTNEY
M
ATHER
|
|
Director
|
Courtney Mather
|
|
|
/
S
/ M
ICHAEL
N
EVIN
|
|
Director
|
Michael Nevin
|
|
|
/
S
/ M
ICHAEL
A. N
UTTER
|
|
Director
|
Michael A. Nutter
|
|
|
/s/ W
ILLIAM
G. P
ARRETT
|
|
Director and Chairman of the Board
|
William G. Parrett
|
|
|
/
S
/ V
IRGINIA
M. W
ILSON
|
|
Director
|
Virginia M. Wilson
|
|
|
(in millions)
|
|
Balance
at beginning
of period
|
|
Additions
charged to
expense
(1)
|
|
Amounts
(credited)
charged to
other income
statement
accounts
(2)
|
|
Deductions
and other, net
of recoveries
(3)(4)
|
|
Balance
at end
of period
|
||||||||||
Allowance for Losses:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2016 Accounts Receivable
|
|
$
|
6
|
|
|
$
|
4
|
|
|
$
|
—
|
|
|
$
|
(3
|
)
|
|
$
|
7
|
|
2015 Accounts Receivable
|
|
6
|
|
|
4
|
|
|
—
|
|
|
(4
|
)
|
|
6
|
|
|||||
2014 Accounts Receivable
|
|
6
|
|
|
3
|
|
|
—
|
|
|
(3
|
)
|
|
6
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Tax Valuation Allowance:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2016 Tax Valuation
|
|
38
|
|
|
—
|
|
|
—
|
|
|
(14
|
)
|
|
24
|
|
|||||
2015 Tax Valuation
|
|
35
|
|
|
—
|
|
|
5
|
|
|
(2
|
)
|
|
38
|
|
|||||
2014 Tax Valuation
|
|
41
|
|
|
—
|
|
|
7
|
|
|
(13
|
)
|
|
35
|
|
(1)
|
Account Receivables: additions charged to expense represent bad debt provisions relate to estimated losses due to credit and similar collectibility issues.
|
(2)
|
Account Receivables: Other charges (credits) relate to adjustments to reserves necessary to reflect events of non-payment such as customer accommodations and contract terminations.
|
(3)
|
Account Receivables: Deductions and other, net of recoveries primarily relates to receivable write-offs, but also includes the impact of foreign currency translation adjustments and recoveries of previously written off receivables.
|
(4)
|
Tax Valuation: Reductions to tax valuation allowance are primarily related to the transfer of balances to the Xerox Corporation due to separation of the companies.
|
2.1
|
Separation and Distribution Agreement, dated as of December 30, 2016, by and between Xerox Corporation and Conduent Incorporated.
|
|
Incorporated by reference to Exhibit 2.1 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
3.1
|
Restated Certificate of Incorporation of Registrant filed with the Department of the State of New York on December 23, 2016.
|
|
Incorporated by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K dated December 23, 2016. (See SEC File Number 001-37817).
|
3.2
|
Amended and Restated By-Laws of Registrant as amended through December 31, 2016.
|
|
Incorporated by reference to Exhibit 3.2 to Registrant’s Current Report on Form 8-K dated December 23, 2016. (See SEC File Number 001-37817).
|
4.1
|
Indenture, dated as of December 7, 2016, among Conduent Finance, Inc., Xerox Business Services, LLC, the Guarantors named therein and U.S. Bank National Association, as trustee.
|
|
Incorporated by reference to Exhibit 4.1 to Registrant’s Current Report on Form 8-K dated December 7, 2016. (See SEC File Number 001-37817).
|
10.1(a)
|
Credit Agreement, dated as of December 7, 2016, among Conduent Incorporated, Xerox Business Services, LLC, Affiliated Computer Services International B.V., Conduent Finance, Inc., the Lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent.
|
|
Incorporated by reference to Exhibit 10.1 to Registrant’s Current Report on Form 8-K dated December 7, 2016. (See SEC File Number 001-37817).
|
10.1(b)
|
First Incremental Agreement, dated as of January 3, 2017, among JPMorgan Chase Bank, N.A., as Administrative Agent and Xerox Business Services, LLC.
|
10.3(a)
|
Transition Services Agreement, dated as of December 30, 2016, by and between Xerox Corporation and Conduent Incorporated.
|
|
Incorporated by reference to Exhibit 10.1 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
10.3(b)
|
Tax Matters Agreement, dated as of December 30, 2016, by and between Xerox Corporation and Conduent Incorporated
|
|
Incorporated by reference to Exhibit 10.2 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
10.3(c)
|
Employee Matters Agreement, dated as of December 30, 2016, by and between Xerox Corporation and Conduent Incorporated.
|
|
Incorporated by reference to Exhibit 10.3 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
10.3(d)
|
Intellectual Property Agreement, dated as of December 30, 2016, by and between Xerox Corporation and Conduent Incorporated
|
|
Incorporated by reference to Exhibit 10.4 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
10.3(e)
|
Trademark License Agreement, dated as of December 30, 2016, by and between Xerox Corporation and Conduent Incorporated
|
|
Incorporated by reference to Exhibit 10.5 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
10.4(a)
|
Joinder Agreement to Agreement, dated December 31, 2016, among Conduent Incorporated, Xerox Corporation, Icahn Partners Master Fund LP, Icahn Partners LP, Icahn Onshore LP, Icahn Offshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Jonathan Christodoro and Carl C. Icahn.
|
|
Incorporated by reference to Exhibit 10.6 to Registrant’s Current Report on Form 8-K dated December 29, 2016. (See SEC File Number 001-37817).
|
10.4(b)
|
Agreement, dated January 28, 2016, among Xerox Corporation, Icahn Partners Master Fund LP, Icahn Partners LP, Icahn Onshore LP, Icahn Offshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Jonathan Christodoro and Carl C. Icahn.
|
|
Incorporated by reference to Exhibit 10.6 to Registrant’s Amendment No. 1 to Form 10 dated August 15, 2016. (See SEC File Number 001-37817).
|
10.5
|
Exchange Agreement dated October 27, 2016 by and among Darwin Deason, Conduent Incorporated and Xerox Corporation.
|
|
Incorporated by reference to Exhibit 10.14 to Registrant’s Amendment No. 5 to Form 10 dated October 28, 2016. (See SEC File Number 001-37817).
|
|
The management contracts or compensatory plans or arrangements listed below that are applicable to the executive officers named in the Summary Compensation Table which will appear in the Registrant’s 2017 Proxy Statement or to our directors are preceded by an asterisk (*).
|
*10.6(a)(i)
|
Registrant’s Performance Incentive Plan dated as of December 15, 2016 (“PIP”).
|
|
Incorporated by reference to Exhibit 4.3 to Registrant’s Registration Statement No. 333-215361. (See SEC File Number 001-37817).
|
*10.6(b)(i)
|
Registrant’s Equity Compensation Plan for Non-Employee Directors dated as of December 15, 2016 (“ECPNED”).
|
|
Incorporated by reference to Exhibit 4.4 to Registrant’s Registration Statement No. 333-215361. (See SEC File Number 001-37817).
|
*10.6(b)(ii)
|
Form of Agreement under the ECPNED.
|
*10.6(c)
|
Letter Agreement dated June 10, 2016 between Xerox Corporation and Ashok Vemuri regarding compensation arrangements.
|
|
Incorporated by reference to Exhibit 99.2 to Xerox Corporation’s Current Report on Form 8-K dated June 14, 2016. (See SEC File Number 001-04471.
|
*10.6(d)
|
Letter Agreement dated September 7, 2016 between Xerox Corporation and Jay Chu regarding compensation arrangements.
|
|
Incorporated by reference to Exhibit 10.10 to Registrant’s Amendment No. 4 to Form 10 dated October 21, 2016. (See SEC File Number 001-37817).
|
*10.6(e)
|
Letter Agreement dated September 29, 2016 between Xerox Corporation and Frederick Koury regarding compensation arrangements.
|
|
Incorporated by reference to Exhibit 10.11 to Registrant’s Amendment No. 4 to Form 10 dated October 21, 2016. (See SEC File Number 001-37817).
|
*10.6(f)
|
Letter Agreement dated July 22, 2016 between Xerox Corporation and J. Michael Peffer regarding compensation arrangements.
|
|
Incorporated by reference to Exhibit 10.12 to Registrant’s Amendment No. 4 to Form 10 dated October 21, 2016. (See SEC File Number 001-37817).
|
*10.6(g)
|
Letter Agreement dated September 6, 2016 between Xerox Corporation and Brian Webb-Walsh regarding compensation arrangements.
|
|
Incorporated by reference to Exhibit 10.13 to Registrant’s Amendment No. 4 to Form 10 dated October 21, 2016. (See SEC File Number 001-37817).
|
21.1
|
List of subsidiaries of Registrant
|
23
|
Consent of PricewaterhouseCoopers LLP.
|
31(a)
|
Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
|
31(b)
|
Certification of CFO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
|
32
|
Certification of CEO and CFO pursuant to 18 U.S.C. §1350 as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002.
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase.
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase.
|
101.INS
|
XBRL Instance Document.
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase.
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase.
|
101.SCH
|
XBRL Taxonomy Extension Schema Linkbase.
|
1.
|
Initial Drawing of Incremental Term Loans
. The Incremental Term Loans shall be denominated in Dollars and shall be made in a single drawing on the Closing Date.
|
2.
|
LIBOR Floor and
Applicable Rate for Incremental Term Loans
.
|
Incremental Term Loans
|
|
Eurocurrency Incremental Term Loans
|
Base Rate Incremental Term Loans
|
5.50%
|
4.50%
|
3.
|
Principal Payments of the Incremental Term Loans
. The (i) scheduled amortization payments under Section 2.09(d) of the Credit Agreement shall be automatically increased to reflect the aggregate principal amount of the Incremental Term Loans and (ii) the Administrative Agent shall take any and all action as may be reasonably necessary to ensure that the Incremental Term Loans are included in each repayment of the Term B Loans on a pro rata basis (with the Incremental Term Loans being fungible with the Term B Loans) based upon the original principal amount of the Term B Loans and the Incremental Term Loans. Any remaining outstanding amount of the Term B Loans (including the Incremental Term Loans) shall be repaid in full on the Term B Loan Maturity Date.
|
4.
|
Incremental Term Loans Voluntary and Mandatory Prepayments; Incremental Term Loans Prepayment Fees
. Scheduled installments of principal of the Incremental Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the Incremental Term Loans in accordance with Sections 2.09 and 2.10 of the Credit Agreement, respectively, as if such Incremental Term Loans were (and on a pro rata basis with) Term B Loans. Without duplication of the obligations of the U.S. Borrower under Section 2.09(a)(iii) of the Credit Agreement, in the event that, on or prior to December 7, 2017, the U.S. Borrower (x) prepays, repays, refinances, substitutes or replaces any Term B Loans or Incremental Term Loans in connection with a Repricing Transaction (including, for the avoidance of doubt, any prepayment made pursuant to Section 2.10(b)(iii) of the Credit Agreement that constitutes a Repricing Transaction), or (y) effects any amendment, waiver or other modification of, or consent under, the Credit Agreement resulting in a Repricing Transaction, the U.S. Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable Term B Lenders and Initial Lenders, (A) in the case of clause (x), a premium of 1.00% of the aggregate principal amount of the Term B Loans or Incremental Term Loans so prepaid, repaid, refinanced, substituted or replaced and (B) in the case of clause (y), a fee equal to 1.00% of the aggregate principal amount of the Term B Loans or Incremental Term Loans outstanding immediately prior
|
5.
|
Use of Proceeds of the Incremental Term Loans
. The U.S. Borrower shall use the proceeds of the Incremental Term Loans for general corporate purposes and to pay fees and expenses related to the Transactions.
|
6.
|
Terms Generally for Incremental Term Loans
. Other than as set forth herein, for all purposes under the Credit Agreement and the other Loan Documents, the Incremental Term Loans shall have the same terms as the Term B Loans and shall be treated for purposes of voluntary and mandatory prepayments (including any applicable prepayment fees and for scheduled principal payments) and all other terms as the same Class of Term Loans as the Term B Loans. The Incremental Term Loans shall, to the extent permitted by applicable tax rules and regulations, be structured as an increase to the Term B Loans that will trade fungibly with such Term B Loans. Upon the funding of the Incremental Term Loans on the Closing Date, the Incremental Term Loans shall automatically and without further action by any Person constitute Term B Loans and Loans and the Initial Lenders shall be Lenders for all purposes of the Credit Agreement and the other Loan Documents. In furtherance of the foregoing, on the Closing Date, there shall commence an initial Interest Period with respect to the Incremental Term Loans, which Interest Period shall end on the last day of the Interest Period applicable to the Term B Loans as in effect immediately prior to the Closing Date.
|
7.
|
[Reserved]
|
8.
|
Initial Lenders
. Each Initial Lender acknowledges and agrees that upon its execution of this First Incremental Agreement it shall become a “Lender” under, and for all purposes of, the Credit Agreement and the other Loan Documents, and shall be subject to and bound by the terms thereof, and shall perform all the obligations of and shall have all rights of a Lender thereunder. For all purposes of this First Incremental Agreement, the Credit Agreement and the other Loan Documents, the term “Initial Lender” shall include each Lender with a commitment to make an Incremental Term Loan or an outstanding Incremental Term Loan.
|
9.
|
Credit Agreement Governs
. Except as set forth in this First Incremental Agreement, the Incremental Term Loans shall otherwise be subject to the provisions of the Credit Agreement and the other Loan Documents. This First Incremental Agreement shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Lenders under the Credit Agreement or any other Loan Document. This First Incremental Agreement shall not constitute a novation of the Credit Agreement or any of the other Loan Documents
|
10.
|
Closing Date Conditions
. The effectiveness of this First Incremental Agreement and the initial borrowing of the Incremental Term Loans shall become effective on the date upon which all of
|
11.
|
Representations and Warranties
. By its execution of this First Incremental Agreement, each Loan Party party hereto hereby represents and warrants to the Administrative Agent, the Initial Lenders and the Lenders that:
|
12.
|
Notice
. For purposes of the Credit Agreement, the initial notice address of the Initial Lenders shall be as separately identified to the Administrative Agent.
|
13.
|
Tax Forms
. For the Initial Lenders, delivered herewith to the Administrative Agent are such forms, certificates or other evidence with respect to United States federal income tax withholding matters as the Initial Lenders may be required to deliver to the Administrative Agent pursuant to the Credit Agreement.
|
14.
|
Recordation of the Incremental Term Loans
. Upon execution and delivery hereof, the Administrative Agent will record the Incremental Term Loans made by the Initial Lenders in the Register.
|
15.
|
Amendment, Modification and Waiver
. This First Incremental Agreement may not be amended, modified or waived except by an instrument or instruments in writing signed and delivered on behalf of each of the parties hereto. This First Incremental Agreement, the Credit Agreement and the other Loan Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof.
|
16.
|
GOVERNING LAW. THIS FIRST INCREMENTAL AGREEMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAW OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY)
.
|
17.
|
Severability
. Any term or provision of this First Incremental Agreement held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.
|
18.
|
Counterparts
. This First Incremental Agreement may be executed in counterparts (including by facsimile or other electronic transmission), each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement.
|
19.
|
WAIVER OF JURY TRIAL
. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS FIRST INCREMENTAL AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.
|
20.
|
Loan Document
. On and after the Closing Date, this First Incremental Agreement shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents (it being understood that for the avoidance of doubt this First Incremental Agreement may be amended or waived solely by the parties hereto as set forth in Section 15 above).
|
21.
|
Consent and Affirmation of the Guarantors
. Each of the Guarantors, in its capacity as a guarantor under the Guarantee Agreement and a Pledgor under the Security Agreement or the Holdings Pledge Agreement, as the case may be, and as a party to each other Loan Document to which it is a party, hereby (i) consents to the execution, delivery and performance of this First Incremental Agreement and agrees that each of the Loan Documents to which it is a party is, and shall continue to be, in full force and effect and is hereby in all respects ratified and confirmed on the Closing Date, except that, on and after the Closing Date, each reference to the “Credit Agreement”, “thereunder”, “thereof”, “therein” or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended and otherwise modified by this First Incremental Agreement and (ii) affirms and confirms its guarantee of the Obligations and its pledge/or grant of a security interest in its assets as Collateral to secure the Obligations with all such security interests continuing in full force and effect after giving effect to this First Incremental Agreement and that the Loan Documents to which each of the Guarantors is a party and all of the Collateral described therein do, and shall continue to, secure the payment of all of the Obligations, including the Incremental Term Loans.
|
22.
|
Affirmation of the Borrower
. The U.S. Borrower hereby (i) agrees that each of the Loan Documents to which it is a party is, and shall continue to be, in full force and effect and is hereby in all respects ratified and confirmed on the Closing Date, except that, on and after the Closing Date, each reference to the “Credit Agreement”, “thereunder”, “thereof”, “therein” or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended and otherwise modified by this First Incremental Agreement and (ii) affirms and confirms its pledge/or grant of a security interest in its assets as Collateral to secure the Obligations with all such security interests continuing in full force and effect after giving effect to this First Incremental Agreement and that the Loan Documents to which it is a party and all of the Collateral described therein do, and shall continue to, secure the payment of all of the Obligations, including the Incremental Term Loans.
|
Initial Lender
|
Incremental Term Loan Commitment Amount
|
||
JPMorgan Chase Bank, N.A.
|
|
$100,000,000
|
|
Name of Subsidiary
|
|
Jurisdiction of Incorporation or Organization
|
MidasPlus, Inc.
|
|
Arizona
|
Healthy Communities Institute Corporation
|
|
California
|
Breakaway Healthcare and Life Sciences LLC
|
|
Colorado
|
Education Sales and Marketing, LLC
|
|
Colorado
|
ESM Chaperone, LLC
|
|
Colorado
|
Wagers & Associates, Inc.
|
|
Colorado
|
ACS Asset Management Group, LLC
|
|
Delaware
|
ACS BPO Services, Inc.
|
|
Delaware
|
ACS BRC Holdings, LLC
|
|
Delaware
|
ACS Consultant Holdings Corporation
|
|
Delaware
|
ACS Defense, LLC
|
|
Delaware
|
ACS EDI Gateway, Inc.
|
|
Delaware
|
ACS Education Loan Services LLC
|
|
Delaware
|
ACS Enterprise Solutions, LLC
|
|
Delaware
|
ACS e-Services, LLC
|
|
Delaware
|
ACS Global, Inc.
|
|
Delaware
|
ACS Health Administration, Inc.
|
|
Delaware
|
ACS Healthcare Analytics, Inc.
|
|
Delaware
|
ACS HR Solutions World Services LLC
|
|
Delaware
|
ACS Human Resources Solutions, LLC
|
|
Delaware
|
ACS Lending, Inc.
|
|
Delaware
|
ACS Middle East, Inc.
|
|
Delaware
|
ACS TMC, Inc.
|
|
Delaware
|
ACS TradeOne Marketing, Inc.
|
|
Delaware
|
ACS Trust I
|
|
Delaware
|
ACS Trust II
|
|
Delaware
|
ACS/ECG Holdings, LLC
|
|
Delaware
|
ACS@Xerox LLC
|
|
Delaware
|
Buck Consultants, LLC
|
|
Delaware
|
Buck Kwasha Securities LLC
|
|
Delaware
|
Bunch CareSolutions, LLC
|
|
Delaware
|
CDR Associates, L.L.C.
|
|
Delaware
|
Conduent Card Service LLC
|
|
Delaware
|
Conduent Finance, Inc.
|
|
Delaware
|
Consilience Software, Inc.
|
|
Delaware
|
Education Services Company, LLC
|
|
Delaware
|
etravelexperts, LLC
|
|
Delaware
|
Government Records Services, Inc.
|
|
Delaware
|
Intellinex LLC
|
|
Delaware
|
ISG Holdings, Inc
|
|
Delaware
|
ISG Services, LLC
|
|
Delaware
|
ParkIndy, LLC
|
|
Delaware
|
RSA Enterprises LLC
|
|
Delaware
|
RSA Medical Exams LLC
|
|
Delaware
|
RSA Medical LLC
|
|
Delaware
|
Specialty I, LLC
|
|
Delaware
|
StrataCare, LLC
|
|
Delaware
|
The National Abandoned Property Processing Corporation
|
|
Delaware
|
Title Records Corporation
|
|
Delaware
|
TMS Health LLC
|
|
Delaware
|
Xerox Audit & Compliance Solutions, LLC
|
|
Delaware
|
Xerox Business Services, LLC
|
|
Delaware
|
Xerox Education Services, LLC
|
|
Delaware
|
Xerox Education Solutions, LLC
|
|
Delaware
|
Xerox European Funding LLC
|
|
Delaware
|
Xerox Export LLC
|
|
Delaware
|
Xerox Federal Solutions, LLC
|
|
Delaware
|
Xerox Government Systems, LLC
|
|
Delaware
|
Xerox HR Solutions, LLP
|
|
Delaware
|
Xerox Mortgage Services, Inc.
|
|
Delaware
|
Xerox Recovery Services, Inc.
|
|
Delaware
|
Xerox Relocation & Assignment Services, LLC
|
|
Delaware
|
Xerox State Healthcare, LLC
|
|
Delaware
|
LearnSomething, Inc.
|
|
Florida
|
ACB Airport Solutions, LLC
|
|
Georgia
|
Digital Information Systems Company, L.L.C.
|
|
Georgia
|
Xerox Transport Solutions, Inc.
|
|
Georgia
|
Wireless Data Services (Operations) Inc.
|
|
Idaho
|
ACS Human Services, LLC
|
|
Indiana
|
Health Technology Acquisition Company
|
|
Indiana
|
Outsourced Administrative Systems, Inc.
|
|
Indiana
|
ACS Image Solutions, Inc.
|
|
Louisiana
|
Xerox Consultant Company, Inc.
|
|
Michigan
|
ACS CompIQ Corporation
|
|
Nevada
|
Xerox Commercial Solutions, LLC
|
|
Nevada
|
TMS Health Patient Access Solutions, LLC
|
|
New Jersey
|
Consultec IPA, Inc.
|
|
New York
|
Smart Data Consulting Corp
|
|
New York
|
Xerox State & Local Solutions, Inc.
|
|
New York
|
LiveBridge, Inc.
|
|
Oregon
|
Newspaper Services Holding, Inc.
|
|
Oregon
|
Statit Software, Inc.
|
|
Oregon
|
Superior Venture Partner, Inc.
|
|
Pennsylvania
|
Xerox HR Solutions, LLC
|
|
Pennsylvania
|
CredenceHealth, Inc.
|
|
Tennessee
|
ACS Protection Services, Inc.
|
|
Texas
|
ACS Securities Services, Inc.
|
|
Texas
|
ACS Welfare Benefit Trust
|
|
Texas
|
Conduent Legal & Compliance Solutions, LLC
|
|
Texas
|
Mercury Fund II, Ltd.
|
|
Texas
|
Transaction Processing Specialists, Inc.
|
|
Texas
|
WDS Global—Texas, Inc.
|
|
Texas
|
Xerox Heritage, LLC
|
|
Virginia
|
Intellinex PS-OS, Inc.
|
|
Washington
|
Wireless Data Services North America Inc.
|
|
Washington
|
Xerox Care and Quality Solutions, Inc.
|
|
Wisconsin
|
Eagle Connect Sh.p.k.
|
|
Albania
|
Voice Star Sh.p.k.
|
|
Albania
|
Market Line S.A.
|
|
Argentina
|
Consilience Software Australasia Pty Ltd
|
|
Australia
|
Xerox Business Services (Australia) Pty. Ltd.
|
|
Australia
|
Wireless Data Services Pty Limited
|
|
Australia
|
Affiliated Computer Services Austria GmbH
|
|
Australia
|
Affiliated Computer Services International (Barbados) Limited
|
|
Barbados
|
Buck Consultants
|
|
Belgium
|
ACS Transportation Services Participacoes Ltda
|
|
Brazil
|
Affiliated Computer Services do Brasil Ltda.
|
|
Brazil
|
ACS HR Solucoes Servicos de Recursos Humanos do Brasil Ltda
|
|
Brazil
|
Affiliated Computer Services Call Center Operations do Brasil LTDA
|
|
Brazil
|
Buck Consultants Limited/Conseilliers Buck Limitee
|
|
Canada
|
Buck Consultants Insurance Agency Limited
|
|
Canada
|
CPAS Systems, Inc.
|
|
Canada
|
Xerox Business Services Canada, Inc.
|
|
Canada
|
ACS HR Solutions Canada Co
|
|
Canada
|
ACS Solutions Chile SA
|
|
Chile
|
ACS Road Technology Services (Beijing) Co. Ltd.
|
|
China
|
Affiliated Computer Services (Tianjin) Co., Ltd.
|
|
China
|
ML Colombia S.A.
|
|
Colombia
|
Penad NV
|
|
Curacao
|
ACS Czech Republic s.r.o.
|
|
Czech Republic
|
Xerox Business Services Dominican Republic, SAS
|
|
Dominican Republic
|
Affiliated Computer Services (Fiji) Limited
|
|
Fiji
|
Affiliated Computer Services Business Process Solutions SAS
|
|
France
|
Xerox Business Solutions (France) SAS
|
|
France
|
Affiliated Computer Services of Germany GmbH
|
|
Germany
|
ACS Holdings (Germany) GmbH
|
|
Germany
|
ACS HR Solutions Deutschland GmbH
|
|
Germany
|
Invoco Holding GmbH
|
|
Germany
|
GIP Dialog Gesellschaft fur Produktinformation mbH
|
|
Germany
|
Invoco Business Solutions GmbH
|
|
Germany
|
Invoco Communication Center GmbH
|
|
Germany
|
Invoco Customer Service GmbH
|
|
Germany
|
Invoco Helpline Communication GmbH
|
|
Germany
|
Invoco Helpline GmbH
|
|
Germany
|
Invoco Marketing & Vetrieb GmbH
|
|
Germany
|
Invoco Media Sales GmbH
|
|
Germany
|
Invoco Multimeida GmbH
|
|
Germany
|
Invoco Sales GmbH
|
|
Germany
|
Invoco Service Center GmbH
|
|
Germany
|
Invoco Service GmbH
|
|
Germany
|
Invoco Services & Sales GmbH
|
|
Germany
|
Invoco Technical Service GmbH
|
|
Germany
|
ACS-BPS (Ghana) Limited
|
|
Ghana
|
Xerox Business Services de Guatemala, Sociedad Anonima
|
|
Guatemala
|
ACS HR Solutions Share Plan Services (Guernsey), Limited
|
|
Guernsey
|
ACS China Solutions Hong Kong Limited
|
|
Hong Kong
|
Xerox Business Solutions (Hong Kong) Limited
|
|
Hong Kong
|
Xerox Business Services India LLP
|
|
India
|
Conduent Ireland Limited
|
|
Ireland
|
Xerox Business Services Italy S.r.l.
|
|
Italy
|
Nuova Karel Soluzioni S.r.l. unipersonale
|
|
Italy
|
Xerox Business Solutions Italia, S.p.A.
|
|
Italy
|
ACS Business Process Solutions (Jamaica) Limited
|
|
Jamaica
|
e-Services Group International (Jamaica) Limited
|
|
Jamaica
|
Sia Rigas Karte
|
|
Latvia
|
Affiliated Computer Services Holdings (Luxembourg) S.A.R.L.
|
|
Luxembourg
|
Xerox Business Services Malaysia Sdn. Bhd.
|
|
Malaysia
|
ACS Malta Limited
|
|
Malta
|
Xerox Business Services de Mexico, S.A. de C.V.
|
|
Mexico
|
Xerox Solutions de Mexico, S. de R.L. de C.V.
|
|
Mexico
|
Phenox Holding B.V.
|
|
Netherlands
|
Buck Consultants BV
|
|
Netherlands
|
Phenox Professionals BV
|
|
Netherlands
|
Affiliated Computer Services International B.V.
|
|
Netherlands
|
ACS HR Solutions Nederland BV
|
|
Netherlands
|
Wilhaave Groep BV
|
|
Netherlands
|
Unamic Holding BV
|
|
Netherlands
|
Unamic/HCN BV
|
|
Netherlands
|
Xerox Business Services (Netherlands) B.V.
|
|
Netherlands
|
Market Line Peru S.A.C.
|
|
Peru
|
ACS Solutions Peru S.A.
|
|
Peru
|
Xerox Business Services Philippines, Inc.
|
|
Philippines
|
ACS Solutions Poland Sp. Z.o.o.
|
|
Poland
|
Affiliated Computer Services of Poland Sp. z.o.o.
|
|
Poland
|
ACS Puerto Rico, LLC
|
|
Puerto Rico
|
Xerox Business Solutions of Puerto Rico, Inc.
|
|
Puerto Rico
|
Xerox Business Services Romania S.r.l.
|
|
Romania
|
Xerox Europe Finance Limited Partnership
|
|
Scotland
|
Wireless Data Services (Asia Pac) PTE Ltd.
|
|
Singapore
|
Wireless Data Services (Proprietary) Limited
|
|
South Africa
|
Affiliated Computer Services of Spain, S.L., Sociedad Unipersonal
|
|
Spain
|
Xerox Business Solutions Spain, S.L.
|
|
Spain
|
e-Services Group (St. Lucia) Ltd.
|
|
St. Lucia
|
Telenamic NV
|
|
Suriname
|
Affiliated Computer Services GmbH
|
|
Switzerland
|
Xerox Business Services (Switzerland) AG
|
|
Switzerland
|
Unamic HCN Musteri Hizmetleri Limited Sirketi
|
|
Turkey
|
ACS Business Process Solutions Limited
|
|
United Kingdom
|
CVG Ltd
|
|
United Kingdom
|
Spur Information Solutions Limited
|
|
United Kingdom
|
Wireless Data Services Limited
|
|
United Kingdom
|
Buck Consultants Limited
|
|
United Kingdom
|
Buck Consultants (Healthcare) Limited
|
|
United Kingdom
|
Buck Consultants (Administration & Investment) Limited
|
|
United Kingdom
|
Buck Consultants Shareplan Trustees Limited
|
|
United Kingdom
|
Buckingham Trustees Limited
|
|
United Kingdom
|
Talking People Limited
|
|
United Kingdom
|
|
/
S
/ P
RICEWATERHOUSE
C
OOPERS
LLP
|
PricewaterhouseCoopers LLP
|
Dallas, Texas
|
March 10, 2017
|
1.
|
I have reviewed this Annual Report on Form 10-K of Conduent Incorporated;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(c)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/
S
/ ASHOK VEMURI
|
|
Ashok Vemuri
Principal Executive Officer
|
|
1.
|
I have reviewed this Annual Report on Form 10-K of Conduent Incorporated;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(c)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/
S
/ BRIAN WEBB-WALSH
|
|
Brian Webb-Walsh
Principal Financial Officer
|
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/
S
/ ASHOK VEMURI
|
|
Ashok Vemuri
Chief Executive Officer
|
|
March 10, 2017
|
|
|
|
/
S
/ BRIAN WEBB-WALSH
|
|
Brian Webb-Walsh
Chief Financial Officer
|
|
March 10, 2017
|
|